OriginClear (OCLN) 10-Q 22 May 23 2023 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2023	May 19, 2023
Document Information Line Items
Entity Registrant Name	ORIGINCLEAR, INC.
Trading Symbol	N/A
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		1,182,602,598
Amendment Flag	false
Entity Central Index Key	0001419793
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Mar. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	333-147980
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	26-0287664
Entity Address, Address Line One	13575 58th Street North
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Clearwater
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33760
City Area Code	(727)
Local Phone Number	440-4603
Title of 12(b) Security	N/A
Security Exchange Name	NONE
Entity Interactive Data Current	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
CURRENT ASSETS
Cash	$ 902,990	$ 636,024
Notes receivable – Fortune Rise Acquisition Corp		718,790
Contracts receivable, net allowance of $17,315 and $17,315, respectively	2,132,326	2,479,123
Fair value investment in securities	22,604	27,125
Contract assets	1,431,791	1,479,491
Prepaid expenses	11,372	25,000
TOTAL CURRENT ASSETS	4,501,083	5,365,553
NET PROPERTY AND EQUIPMENT	169,241	177,069
OTHER ASSETS
Long term assets held for sale	400,000	400,000
SPAC Class B common shares purchase cost	400,000	400,000
Fair value investment-securities	2,400	2,400
Trademark	4,467	4,467
TOTAL OTHER ASSETS	806,867	806,867
TOTAL ASSETS	5,477,191	6,349,489
Current Liabilities
Accounts payable and other payable	2,858,453	3,784,747
Accrued expenses	1,811,343	1,633,904
Cumulative preferred stock dividends payable	418,807	415,597
Contract liabilities	916,935	932,458
Tax liability 83(b)	15,600	15,600
Customer deposit	146,453	146,453
Warranty reserve	20,000	20,000
Line of credit	200,000
Loan payable, merchant cash advance	30,646	30,646
Loans payable, SBA	149,157	149,790
Derivative liabilities	5,703,527	9,578,904
Series F 8% Preferred Stock, 60 and 160 shares issued and outstanding, redeemable value of $60,000 and $160,000 respectively	60,000	60,000
Series G 8% Preferred Stock, 25 and 25 shares issued and outstanding, respectively, redeemable value of $25,000 and $25,000, respectively	25,000	25,000
Series I 8% Preferred Stock, 25 and 25 shares issued and outstanding, respectively, redeemable value of $25,000 and $25,000, respectively	25,000	25,000
Series K 8% Preferred Stock, 407.15 and 407.15 shares issued and outstanding, respectively, redeemable value of $407,150 and $580,650, respectively	407,150	407,150
Convertible secured promissory note (Note 5)	6,734,839	1,347,500
Convertible promissory notes, net of discount of $0 and $0, respectively (Note 5)	2,042,983	1,037,983
Total Current Liabilities	21,565,893	19,610,732
Convertible promissory notes, net of discount of $0 and $0, respectively	883,772	1,888,772
Total Long Term Liabilities	883,772	1,888,772
Total Liabilities	22,449,665	21,499,504
COMMITMENTS AND CONTINGENCIES (See Note 11)
Convertible preferred stock, total	9,986,772	10,866,772
SHAREHOLDERS’ DEFICIT
Preferred stock, $0.0001 par value, 600,000,000 shares authorized
1,677 and 1,475 shares of Series A issued and outstanding, respectively
1,001,000 and 1,001,000 shares of Series C issued and outstanding, respectively
31,500,000 and 31,500,000 shares of Series D-1 issued and outstanding, respectively	3,150	3,150
Subscription payable for purchase of equipment	100,000	100,000
Preferred treasury stock,1,000 and 1,000 shares outstanding, respectively
Common stock, $0.0001 par value, 16,000,000,000 shares authorized 1,118,939,374 and 1,013,369,185 equity shares issued and outstanding, respectively	111,895	101,337
Additional paid in capital - Common stock	83,993,739	82,745,503
Accumulated other comprehensive gain/(loss)	(132)	(132)
Accumulated deficit	(111,167,898)	(108,966,645)
TOTAL SHAREHOLDERS’ DEFICIT	(26,959,246)	(26,016,787)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	5,477,191	6,349,489
Series J Convertible Preferred Stock
Current Liabilities
Convertible preferred stock	210,000	210,000
Series L Convertible Preferred Stock
Current Liabilities
Convertible preferred stock	320,495	320,495
Series M Preferred Stock
Current Liabilities
Convertible preferred stock	1,007,500	1,007,500
Series O 8% Convertible Preferred Stock
Current Liabilities
Convertible preferred stock	190,000	230,000
Series P Convertible Preferred Stock
Current Liabilities
Convertible preferred stock	30,000	30,000
Series Q 12% Convertible Preferred Stock
Current Liabilities
Convertible preferred stock	590,000	615,000
Series R 12% Convertible Preferred Stock
Current Liabilities
Convertible preferred stock	2,363,000	2,828,000
Series S 12% Convertible Preferred Stock
Current Liabilities
Convertible preferred stock	145,000	170,000
Series U Convertible Preferred Stock
Current Liabilities
Convertible preferred stock	385,000	385,000
Series W 12% Convertible Preferred Stock
Current Liabilities
Convertible preferred stock	819,500	819,500
Series X Convertible Preferred Stock
Current Liabilities
Convertible preferred stock		250,000
Series Y Convertible Preferred Stock
Current Liabilities
Convertible preferred stock	3,676,277	3,751,277
Series Z Convertible Preferred Stock
Current Liabilities
Convertible preferred stock	$ 250,000	$ 250,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Contracts receivable, net allowance of respectively (in Dollars)	$ 17,315	$ 17,315
Convertible promissory notes, net of discount (in Dollars)	0	0
Convertible promissory notes, net of discount (in Dollars)	$ 0	$ 0
Convertible preferred stock, shares issued	25
Preferred treasury stock, shares outstanding	1,000	1,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	16,000,000,000	16,000,000,000
Common stock, shares issued	1,118,939,374	1,013,369,185
Common stock, shares outstanding	1,118,939,374	1,013,369,185
Series F 8% Preferred Stock
Preferred stock, shares issued	60	160
Preferred stock, shares outstanding	60	160
Preferred stock, redeemable value (in Dollars)	$ 60,000	$ 160,000
Series G 8% Preferred Stock
Preferred stock, shares issued	25	25
Preferred stock, shares outstanding	25	25
Preferred stock, redeemable value (in Dollars)	$ 25,000	$ 25,000
Series I 8% Preferred Stock
Preferred stock, shares issued	25	25
Preferred stock, shares outstanding	25	25
Preferred stock, redeemable value (in Dollars)	$ 25,000	$ 25,000
Series K 8% Preferred Stock
Preferred stock, shares issued	407.15	407.15
Preferred stock, shares outstanding	407.15	407.15
Preferred stock, redeemable value (in Dollars)	$ 407,150	$ 580,650
Series J Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 210,000	$ 210,000
Convertible preferred stock, shares issued	210	210
Convertible preferred stock, shares outstanding	210	210
Series L Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 320,495	$ 320,495
Convertible preferred stock, shares issued	320.495	320.495
Convertible preferred stock, shares outstanding	320.495	320.495
Series M Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 1,007,500	$ 1,007,500
Convertible preferred stock, shares issued	40,300	40,300
Convertible preferred stock, shares outstanding	40,300	40,300
Series O 8% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 190,000	$ 230,000
Convertible preferred stock, shares issued	190	230
Convertible preferred stock, shares outstanding	190	230
Series P Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 30,000	$ 30,000
Convertible preferred stock, shares issued	30	30
Convertible preferred stock, shares outstanding	30	30
Series Q 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 590,000	$ 615,000
Convertible preferred stock, shares issued	590	615
Convertible preferred stock, shares outstanding	590	615
Series R 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 2,363,000	$ 2,828,000
Convertible preferred stock, shares issued	2,363	2,828
Convertible preferred stock, shares outstanding	2,363	2,828
Series S 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 145,000	$ 170,000
Convertible preferred stock, shares issued	145	170
Convertible preferred stock, shares outstanding	145	170
Series U Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 385,000	$ 385,000
Convertible preferred stock, shares issued	385	385
Convertible preferred stock, shares outstanding	385	385
Series W 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 819,500	$ 819,500
Convertible preferred stock, shares issued	819.5	819.5
Convertible preferred stock, shares outstanding	819.5	819.5
Series X Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 0	$ 250,000
Convertible preferred stock, shares issued	0	250
Convertible preferred stock, shares outstanding	0	250
Series Y Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 3,676,277	$ 3,751.277
Convertible preferred stock, shares issued	3,676,277	3,751,277
Convertible preferred stock, shares outstanding	3,676,277	3,751,277
Series Z Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 250,000	$ 250,000
Convertible preferred stock, shares issued	250	250
Convertible preferred stock, shares outstanding	250	250
Preferred Stock
Preferred stock, shares issued	600,000,000	600,000,000
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Series A Preferred Stock
Preferred stock, shares issued	1,677	1,677
Preferred stock, shares outstanding	1,475	1,475
Series C Preferred Stock
Preferred stock, shares issued	1,001,000	1,001,000
Preferred stock, shares outstanding	1,001,000	1,001,000
Series D-1 Preferred Stock
Preferred stock, shares issued	31,500,000	31,500,000
Preferred stock, shares outstanding	31,500,000	31,500,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Sales	$ 2,006,394	$ 1,234,105
Cost of Goods Sold	1,875,319	1,458,855
Gross Profit	131,075	(224,750)
Operating Expenses
Selling and marketing expenses	814,222	646,184
General and administrative expenses	1,088,770	880,260
Depreciation and amortization expense	7,829	10,733
Total Operating Expenses	1,910,821	1,537,177
Loss from Operations	(1,779,746)	(1,761,927)
OTHER INCOME (EXPENSE)
Other income	126,879
Impairment of receivable from SPAC	(1,657,920)
Gain on write off of loans payable		75,000
Loss on conversion of preferred stock		(210,997)
Loss on exchange of preferred stock		(112,778)
Unrealized gain (loss) on investment securities	(4,521)
Conversion and settlement value added to note purchase agreements	(2,505,339)
Gain (Loss) on net change in derivative liability and conversion of debt	3,875,377	(1,326,713)
Interest and dividend expense	(255,983)	(238,852)
TOTAL OTHER (EXPENSE) INCOME	(421,507)	(1,814,340)
NET LOSS	$ (2,201,253)	$ (3,576,267)
BASIC (in Dollars per share)	$ 0	$ (0.01)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING,
BASIC (in Shares)	1,062,100,064	416,397,236

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
DILUTED	$ 0	$ (0.01)
DILUTED	1,062,100,064	416,397,236

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders’ Deficit - USD ($)	Preferred stock	Mezzanine Equity	Common stock	Additional Paid-in- Capital	Subscription Payable	Accumulated Other Comprehensive loss	Accumulated Deficit	Total
Balance at Dec. 31, 2021	$ 3,304	$ 10,183,092	$ 30,688	$ 75,720,147	$ 100,000	$ (132)	$ (98,175,924)	$ (22,321,917)
Balance (in Shares) at Dec. 31, 2021	33,038,213		306,883,932
Common stock issuance for conversion of debt and accrued interest			$ 1,246	118,388				119,634
Common stock issuance for conversion of debt and accrued interest (in Shares)			12,461,909
Common stock issued at fair value for services			$ 1,333	337,391				338,724
Common stock issued at fair value for services (in Shares)			13,314,289
Common stock issued for conversion of Series L Preferred stock		(123,580)	$ 1,452	122,127				123,579
Common stock issued for conversion of Series L Preferred stock (in Shares)			14,528,106
Common stock issued for Series O Preferred stock dividends			$ 26	(26)
Common stock issued for Series O Preferred stock dividends (in Shares)			261,707
Common stock issued for conversion of Series R Preferred stock		(378,267)	$ 2,612	375,655				378,267
Common stock issued for conversion of Series R Preferred stock (in Shares)			26,120,791
Common stock issued for conversion of Series T Preferred stock		(145,000)	$ 1,719	143,281				145,000
Common stock issued for conversion of Series T Preferred stock (in Shares)			17,193,676
Common stock issued for conversion of Series U Preferred stock		(431,500)	$ 2,279	429,221				431,500
Common stock issued for conversion of Series U Preferred stock (in Shares)			22,794,493
Common stock issued for conversion of Series W Preferred stock		(10,000)	$ 69	9,931				10,000
Common stock issued for conversion of Series W Preferred stock (in Shares)			694,446
Common stock issued for make good shares for Series R Preferred stock			$ 104	(104)
Common stock issued for make good shares for Series R Preferred stock (in Shares)			1,041,662
Common stock issued for conversion settlement			$ 11,101	(11,101)
Common stock issued for conversion settlement (in Shares)			111,010,481
Issuance of Series Y Preferred stock through a private placement		1,244,200
Issuance of Series Z Preferred stock through a private placement		250,000
Exchange of Series F Preferred Stock for Series Q Preferred stock		100,000
Exchange of Series K Preferred Stock for Series W Preferred stock		35,000
Loss on conversion of Preferred Stock				210,997				210,997
Net Loss							(3,576,267)	(3,576,267)
Balance at Mar. 31, 2022	$ 3,304	10,723,945	$ 52,630	77,455,907	100,000	(132)	(101,752,191)	(24,140,482)
Balance (in Shares) at Mar. 31, 2022	33,038,213		526,305,492
Balance at Dec. 31, 2022	$ 3,150	10,866,772	$ 101,337	82,745,503	100,000	(132)	(108,966,645)	(26,016,787)
Balance (in Shares) at Dec. 31, 2022	32,502,475		1,013,369,185
Common stock issued for cash per equity financing agreement			$ 1,865	128,719				130,584
Common stock issued for cash per equity financing agreement (in Shares)			18,645,028
Common stock issued at fair value for services			$ 2,371	250,839				253,210
Common stock issued at fair value for services (in Shares)			23,716,123
Common stock issued for conversion of Series O Preferred stock		(40,000)	$ 772	39,228				40,000
Common stock issued for conversion of Series O Preferred stock (in Shares)			7,722,008
Common stock issued for conversion of Series Q Preferred stock		(25,000)	$ 421	24,579				25,000
Common stock issued for conversion of Series Q Preferred stock (in Shares)			4,208,756
Common stock issued for Series O Preferred stock dividends			$ 24	(24)
Common stock issued for Series O Preferred stock dividends (in Shares)			238,003
Common stock issued for conversion of Series R Preferred stock		(365,000)	$ 7,065	357,935				365,000
Common stock issued for conversion of Series R Preferred stock (in Shares)			70,652,445
Common stock issued for conversion of Series S Preferred stock		(25,000)	$ 421	24,579				25,000
Common stock issued for conversion of Series S Preferred stock (in Shares)			4,208,756
Common stock issued for conversion of Series Y Preferred stock		(420,000)	$ 6,366	413,634				420,000
Common stock issued for conversion of Series Y Preferred stock (in Shares)			63,656,525
Common stock issued for conversion settlement			$ 8,584	(8,584)
Common stock issued for conversion settlement (in Shares)			85,836,889
Common stock issued for alternative vesting			$ 883	(883)
Common stock issued for alternative vesting (in Shares)			8,830,859
Issuance of Series A Preferred stock granted to Series Y investors (in Shares)	202
Issuance of Series Y Preferred stock through a private placement		345,000
Exchange of Series R Preferred Stock for WODI secured convertible note		(100,000)
Exchange of Series X Preferred Stock for WODI secured convertible note		(250,000)
Redemption of common stock for note purchase agreement			$ (18,214)	18,214
Redemption of common stock for note purchase agreement (in Shares)			(182,145,203)
Net Loss							(2,201,253)	(2,201,253)
Balance at Mar. 31, 2023	$ 3,150	$ 9,986,772	$ 111,895	$ 83,993,739	$ 100,000	$ (132)	$ (111,167,898)	$ (26,959,246)
Balance (in Shares) at Mar. 31, 2023	32,502,677		1,118,939,374

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (loss)	$ (2,201,253)	$ (3,576,267)
Depreciation and amortization	7,829	10,733
Common and preferred stock issued for services	253,210	338,724
(Gain) Loss on net change in valuation of derivative liability	(3,875,377)	1,326,713
Conversion and settlement value added to note purchase agreements	2,505,339
Debt discount recognized as interest expense		3,743
Net unrealized (gain)loss on fair value of securities	4,521	112,778
Impairment of receivable from SPAC	1,657,920
(Gain) Loss on conversion of preferred stock		210,997
Gain on write off of payable		(50,000)
Contracts receivable	346,797	1,111,221
Contract asset	47,700	(403,035)
Prepaid expenses and other assets	13,628	748
Accounts payable	(921,795)	(13,672)
Accrued expenses	177,439	47,873
Contract liabilities	(15,523)	607,879
NET CASH USED IN OPERATING ACTIVITIES	(1,999,565)	(271,565)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Notes receivable – Fortune Rise Acquisition Corp	(1,657,920)
Purchase of fixed assets	(4,500)	(4,500)
NET CASH USED IN INVESTING ACTIVITIES	(1,662,420)	(4,500)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on capital lease		(2,272)
Payments on loan payable, SBA	(633)
Line of Credit	200,000
Equity financing through the purchase of common shares	130,584
Net payments on cumulative preferred stock dividends payable	3,210	(4,369)
Convertible secured promissory notes	2,532,000
Net proceeds for issuance of preferred stock for cash - mezzanine classification	345,000	1,430,700
NET CASH PROVIDED BY FINANCING ACTIVITIES	3,210,161	1,424,059
NET INCREASE (DECREASE) IN CASH	(451,824)	1,147,994
CASH BEGINNING OF PERIOD	1,354,814	706,421
CASH END OF PERIOD	902,990	1,854,415
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest and dividends paid	255,983	180,898
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON-CASH TRANSACTIONS
Common stock issued at fair value for conversion of debt, plus accrued interest, and other fees		119,634
Issuance of Series O dividends	24	26
Preferred stock converted to common stock - mezzanine	875,000	1,088,347
Exchange of Series R Preferred Stock for WODI secured convertible note	100,000
Conversion of debt to mezzanine preferred stock		135,000
Common stock issued as settlement	8,584	11,101
Exchange of Series X Preferred Stock for WODI secured convertible note	250,000
Shares issued for alternate vesting	883
Redemption of shares for secured promissory notes	$ 18,214

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2023
Basis of Presentation [Abstract]
Basis of Presentation	1. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of OriginClear, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2022. The Company operates an outsourced water treatment business called Water On Demand (“WOD”), which it conducts through its wholly owned subsidiary, Water on Demand, Inc. (“WODI”). The WOD model offers private businesses water self-sustainability as a service, the ability to pay for water treatment and purification services on a per-gallon basis, with a percentage of net profits paid to investors and stakeholders. This is commonly known as Design-Build-Own-Operate or “DBOO”. In addition to WODI, four subsidiaries were originally established to house capital dedicated to this program. For efficiency, during the three months ended March 31, 2023, the Company reorganized these subsidiaries into a single WOD Subsidiary. As of the period ended March 31, 2023, the Company received aggregate funding in the amount of $345,000 through the sale of its Series Y Preferred Stock dedicated to the Water on Demand program. The Company is currently evaluating opportunities to contract with commercial customers to outsource water treatment as a managed service and pay by the gallon for the treatment of its dirty water as an alternative to having to come up with significant up-front capital. While these evaluations are ongoing, without guarantee as to when or if these will take place, the Company is placing funds from the sale of Series Y Preferred Stock into various company initiatives to support WOD. While there is no obligation to do so, the Company has made special distributions of funds to Series Y holders in lieu of share of profits, paid after the end of each quarter. Going Concern The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. These factors, among others raise substantial doubt about the Company’s ability to continue as a going concern. Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2022 expressed substantial doubt about our ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, achieving a level of profitable operations and receiving additional cash infusions. During the three months ended March 31, 2023, the Company obtained funds from the issuance of convertible note agreements and from sale of its preferred stock. Management believes this funding will continue from its’ current investors and from new investors. The Company also generated revenue of $2,006,394 and has standing purchase orders and open invoices with customers, which will provide funds for operations. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case of equity financing.

Summary of Significant Accounti

Summary of Significant Accounting Polices	3 Months Ended
	Mar. 31, 2023
Summary of Significant Accounting Polices [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., Water on Demand Inc., Water On Demand1, Inc., Water On Demand2, Inc., Water On Demand3, Inc. and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities. As of March 31, 2023, the Company reorganized Water On Demand2, Inc. and Water On Demand3, Inc and combined the subsidiaries into Water On Demand1, Inc. Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. During the reorganization of Water On Demand1, Inc., Water On Demand2, Inc., and Water On Demand3, Inc., the restricted cash balance on the financial statements as of December 31, 2022 was combined with the overall cash balance of the consolidated Company during the three months ended March 31, 2023. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Net Earnings (Loss) per Share Calculations Basic loss per share calculation is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similarly to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted earnings per share were not the same as the basic loss per share for the three months ended March 31, 2023 and 2022, respectively, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. For the Three Months 2023 2022 Loss to common shareholders (Numerator) $ (2,201,253 ) $ (3,576,267 ) Basic weighted average number of common shares outstanding (Denominator) 1,062,100,064 416,397,236 Diluted weighted average number of common shares outstanding (Denominator) 1,062,100,064 416,397,236 The Company excludes issuable shares from warrants, convertible notes and preferred stock, if their impact on the loss per share is anti-dilutive and includes the issuable shares if their impact is dilutive. Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs. Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was $17,315 and $17,315 as of March 31, 2023 and December 31, 2022, respectively. The net contract receivable balance was $2,132,326 and $2,479,123 at March 31, 2023 and December 31, 2022, respectively. Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill at March 31, 2023 and 2022, respectively, and determined there was no impairment of indefinite lived intangibles and goodwill. Prepaid Expenses The Company records expenditures that have been paid in advance as prepaid expenses. The prepaid expenses are initially recorded as assets, because they have future economic benefits, and are expensed at the time the benefits are realized. The prepaid expenses balance was $11,372 and $25,000 at March 31, 2023 and December 31, 2022, respectively. Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years 3/31/2023 12/31/22 Machinery and Equipment $ 383,569 $ 383,569 Computer Equipment 66,493 66,493 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 607,012 607,012 Less accumulated depreciation (437,771 ) (429,943 ) Net Property and Equipment $ 169,241 $ 177,069 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that the facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the three months ended March 31, 2023 and 2022, was $7,829 and $10,733, respectively. Other Assets Long Term Asset Held for Sale On March 1, 2021, the Company issued an aggregate of 630 shares of Series T Preferred Stock to an accredited investor (the “Purchaser’’) per terms of a Securities Purchase Agreement (the “SPA”). Per the SPA, the Company agreed to sell to Purchaser, and Purchaser agreed to purchase from the Company, 630 shares of the Company’s Series T, and two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per share per terms of the SPA, which may be exercised at any time in whole or in part. The purchaser and the Company agreed that in lieu of the purchase price for the Series T, the Purchaser transferred to the Company real property, with an aggregate value agreed to be $630,000 based on an appraisal from an international independent company. The real property consists of residential real estate in Buenos Aires Argentina valued at $580,000, and eight undeveloped lots valued at $50,000 in Terralta private neighborhood development. The real property exchanged for 630 shares of Series T was recorded at $630,000 and reflected on the balance sheet as a long term asset for sale. The Company has actively listed the residential real property for sale since July 2021. However, based on indicator of impairment, during the year ended December 31, 2021, the Company adjusted the original value of the long term asset for sale from $630,000 to $514,000 on the balance sheet and recorded an impairment of $116,000 in the consolidated financial statements Throughout the year 2022, the Company continued its efforts to sell the residential real property and after evaluating several offers, it is now actively pursuing an offer for $400,000, which is $114,000 below the previously adjusted value and is indicative of the current real estate market conditions in Buenos Aires, Argentina. Based on that indicator of impairment, during the year ended December 31, 2022, the Company further adjusted the previous value of the long term asset for sale from $514,000 to $400,000 on the balance sheet and recorded an impairment of $114,000 in the consolidated financial statements. Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants vest immediately and the total stock-based compensation charge is recorded in the period of the measurement date. Accounting for Derivatives The Company evaluates all its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not to recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2023, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of March 31, 2023. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, March 31, 2023 $ 25,004 $ 25,004 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, March 31, 2023 $ 5,703,527 $ - $ - $ 5,703,527 The derivative liabilities consist of $4,331,635 for convertible notes outstanding and $1,371,892 for warrants outstanding for an aggregate of $5,703,527. The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of December 31, 2022 $ 9,578,904 Net loss on conversion of debt and change in derivative liabilities (3,875,377 ) Balance as of March 31, 2023 $ 5,703,527 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 3/31/2023 Risk free interest rate 4.64% - 4.97% Stock volatility factor 7.02% - 152.0% Weighted average expected option life 6 mos - 5 yrs Expected dividend yield None Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated. Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income. Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered. Reclassification Certain amounts in the prior period financial statements have been reclassified to conform to the presentation used in the current financial statements for comparative purpose. There was no material effect on the Company’s previously issued financial statements. Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers. Recently Issued Accounting Pronouncements Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Capital Stock

Capital Stock	3 Months Ended
	Mar. 31, 2023
Capital Stock [Abstract]
CAPITAL STOCK	3. CAPITAL STOCK OriginClear, Inc Preferred Stock Series C On March 14, 2017, the Board of Directors authorized the issuance of 1,000 shares of Series C preferred stock, par value $0.0001 per share, to T. Riggs Eckelberry in exchange for his continued employment with the Company. The holder of Series C preferred stock is not entitled to receive dividends, is not entitled to any liquidation preference and shares of Series C preferred stock does not have any conversion rights. The Series C Preferred Stock entitles the holder to 51% of the total voting power of our stockholders. The purchase price of the Series C preferred stock was $0.0001 per share representing a total purchase price of $0.10 for 1,000 shares. As of March 31, 2023, there were 1,000 shares of Series C preferred stock outstanding held by Mr. Eckelberry. Series D-1 On April 13, 2018, the Company designated 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock are not entitled to dividends and do not have a liquidation preference. Each share of Series D-1 preferred stock is convertible into 0.0005 of one share of common stock. The Series D-1 preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of our outstanding common stock, which amount may be increased to 9.99% at the holders discretion upon 61 days’ written notice. As of March 31, 2023, there were 31,500,000 shares of Series D-1 preferred stock issued and outstanding. Series E On August 14, 2018, the Company designated 4,000,000 shares of its authorized preferred stock as Series E preferred stock. The shares of Series E preferred stock are not entitled to dividends and not have a liquidation preference. Each share of Series E preferred stock is convertible into 0.05 shares of common stock. The shares of Series E preferred stock do not carry any voting rights. The Series E preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of our outstanding common stock which amount may be increased to 9.99% at the holder’s discretion. During the year ended December 31, 2022, the Company issued an aggregate of 76,865 shares of common stock upon conversion of 1,537,213 shares of Series E preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of , there were no shares of Series E preferred stock issued and outstanding. Series F On August 14, 2018, the Company designated 6,000 shares as Series F preferred stock. The shares of Series F preferred stock have a liquidation preference equal to the stated value of $1,000 per share plus any accrued but unpaid dividends. The Series F preferred stock is not convertible into common stock. The holders of outstanding shares of Series F preferred stock are entitled to quarterly dividends at the annual rate of 8% of the stated value, in preference to any dividends on the common stock. The shares of Series F preferred stock do not carry any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company was required to redeem all outstanding shares of Series F preferred stock on September 1, 2020. As of March 31, 2023, the Company had 60 outstanding shares of Series F preferred stock, which the Company was required to, and failed to redeem on September 1, 2020, and remains in default for an aggregate redemption price (equal to the stated value) of $60,000 Series G On January 16, 2019, the Company designated 6,000 shares as Series G preferred stock, each share having a stated value of $1,000 per share and holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. The Series G preferred stock does not have voting rights, except as required by law and is not convertible into common stock. The Company may, in its sole discretion, at any time while the Series G preferred stock is outstanding, redeem all or any portion of the outstanding Series G preferred stock at a price equal to the stated value plus any accrued but unpaid dividends. The Company was required to redeem such shares of Series G preferred stock on April 30, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser received shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. As of March 31, 2023, there were 25 shares of Series G preferred stock issued and outstanding, which the Company was required to, and failed to redeem on April 30, 2021, for an aggregate redemption price (equal to the stated value) of $25,000. Series I On April 3, 2019, the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I is not entitled to any voting rights except as may be required by applicable law, and are not convertible into common stock. The Company has the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series I between May 2, 2021 and June 10, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. As of , there were 25 shares of Series I preferred stock issued and outstanding which the Company was required to, and failed to redeem by June 10, 2021, and was and remains in default for an aggregate redemption price (equal to the stated value) of $25,000 Series J On April 3, 2019, the Company designated 100,000 shares of preferred stock as Series J. The Series J has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series J preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series J COD, which includes certain make-good shares for certain prior investors. As of , there were 210 shares of Series J preferred stock issued and outstanding Series K On June 3, 2019, the Company designated 4,000 shares of preferred stock as Series K. The Series K has a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K is not entitled to any voting rights except as may be required by applicable law, and is not convertible into common stock. The Company has the right to redeem the Series K at any time while the Series K are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series K two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company is required to redeem such shares of Series K between August 5, 2021 and April 24, 2022, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. As of , there were 407 shares of Series K preferred stock issued and outstanding which the Company was required to, and failed to redeem by April 24, 2022, and was and remains in default for an aggregate redemption price (equal to the stated value) of $407,150 Series L On June 3, 2019, the Company designated 100,000 shares of preferred stock as Series L. The Series L has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series L COD, which includes certain make-good shares for certain prior investors. As of , there were 321 shares of Series L preferred stock issued and outstanding. Series M Pursuant to the Amended and Restated Certificate of Designation of Series M Preferred Stock filed with the Secretary of State of Nevada on July 1, 2020, the Company designated 800,000 shares of its preferred stock as Series M Preferred Stock. Each share of Series M Preferred Stock has a stated value of $25. The Series M Preferred Stock is not convertible into common stock. The holders of outstanding shares of Series M Preferred Stock are entitled to receive dividends, at the annual rate of 10%, payable monthly, payable in preference and priority to any payment of any dividend on the common stock. The Series M Preferred Stock is entitled to a liquidation preference in an amount equal to $25 per share plus any declared but unpaid dividends, before any payments to holders of common stock. The Series M Preferred Stock have no pre-emptive or subscription rights, and there are no sinking fund provisions applicable to the Series M Preferred Stock. The Series M Preferred Stock does not have voting rights, except as required by law and with respect to certain protective provisions set forth in the Certificate of Designation of Series M Preferred Stock. To the extent it may lawfully do so, the Company may, in its sole discretion, at any time when there are outstanding shares of Series M Preferred Stock, redeem any or all of the then outstanding shares of Series M Preferred Stock at a redemption price of $37.50 per share (150% of the stated value) plus any accrued but unpaid dividends. As of March 31, 2023, there were 40,300 shares of Series M preferred stock issued and outstanding. Series O On April 27, 2020, the Company designated 2,000 shares of preferred stock as Series O preferred stock. The Series O preferred stock has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends (i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O preferred stock has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series O preferred stock has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series O preferred stock. The Series O preferred stock does not have voting rights except as required by law. The Series O preferred stock is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series O preferred stock being converted by the conversion price, provided that, the Series O may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series O preferred stock at any time while the Series O preferred stock are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the three months ended the Company issued an aggregate of 7,722,008 shares of common stock upon conversion of 40 shares of Series O preferred stock and issued an aggregate of 238,003 shares of common stock in prorated 4% annualized dividends which were recorded as interest expense. The shares were issued within the terms of the agreement and no gain or loss was recognized. , there were 190 shares of Series O preferred stock issued and outstanding Series P On April 27, 2020, the Company designated 500 shares of preferred stock as Series P preferred stock. The Series P preferred stock has a stated value of $1,000 per share, and entitles holders to receive dividends on an as-converted basis with the Company’s common stock. The Series P preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Certificate of Designation of Series P preferred stock, which includes certain make-good shares for certain prior investors, and provided that, the Series P preferred stock may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Series P preferred stock entitles the holders to a payment on an as-converted and pari-passu basis with the common stock upon any liquidation. The Series P preferred stock has no preemptive or subscription rights, and there is no sinking fund or redemption provisions applicable to the Series P preferred stock. The Series P preferred stock votes on an as-converted basis with the common stock, subject to the beneficial ownership limitation. As of , there were 30 shares of Series P preferred stock issued and outstanding. Series Q On August 21, 2020, the Company designated 2,000 shares of preferred stock as Series Q Preferred Stock. The Series Q Preferred Stock has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series Q Preferred Stock has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series Q Preferred Stock has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series Q Preferred Stock. The Series Q Preferred Stock does not have voting rights except as required by law. The Series Q Preferred Stock is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series Q Preferred Stock being converted by the conversion price, provided that, the Series Q may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series Q Preferred Stock at any time while the Series Q Preferred Stock are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the three months ended , the Company issued an aggregate of 4,208,756 shares of common stock upon conversion of 25 shares of Series Q preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of , there were 590 shares of Series Q preferred stock issued and outstanding Series R On November 16, 2020, the Company designated 5,000 shares of preferred stock as Series R. The Series R has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 10% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series R holders are not entitled to any voting rights except as may be required by applicable law. The Series R is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series R being converted by the conversion price; certain prior investors will also be entitled to certain make-good shares; provided that, the Series R may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series R at any time while the Series R are outstanding at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid cash dividends, or, if paid in shares of common stock, in an amount of shares determined by dividing the stated value being redeemed by the conversion price. The subscribers were offered warrants with the purchase of Series R. During the three months ended , the Company issued an aggregate of 70,652,445 shares of common stock upon conversion of 365 shares of Series R preferred stock and the Company’s subsidiary, Water On Demand, Inc., executed a Secured Note Purchase Agreement upon redemption of an aggregate of 100 shares of Series R preferred stock. The shares were issued and exchanged within the terms of the agreement and no gain or loss was recognized. As of , there were 2,363 shares of Series R preferred stock issued and outstanding Series S On February 5, 2021, the Company designated 430 shares of preferred stock as Series S. The Series S has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series S holders are not entitled to any voting rights except as may be required by applicable law. The Series S is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series S being converted by the conversion price, provided that, the Series S may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series S at any time while the Series S are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. During the three months ended , the Company issued an aggregate of 4,208,756 shares of common stock upon conversion of 25 shares of Series S preferred stock. Series T On February 24, 2021, the Company designated 630 shares of preferred stock as Series T. The Series T had a stated value of $1,000 per share. The Series T holders were not entitled to any voting rights except as may be required by applicable law. The Series T was convertible into common stock of the Company pursuant to the Series T COD, provided that, the Series T was not to be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may have been increased up to 9.99% upon 61 days’ written notice). On March 1, 2021, the Company issued an aggregate of 630 shares of Series T Preferred Stock to an accredited investor (the “Purchaser’’) per terms of a Securities Purchase Agreement (the “SPA”). Per the SPA, the Company agreed to sell to Purchaser, and Purchaser agreed to purchase from the Company, 630 shares of the Company’s Series T, and two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per share per terms of the SPA, which expired on March 1, 2023. The purchaser of the Series T and the Company agreed that in lieu of the purchase price for the Series T, the Purchaser transferred to the Company real property, with an aggregate value agreed to be $630,000 based on an appraisal from an international independent company. The real property consists of residential real estate in Buenos Aires Argentina originally valued at $580,000, and eight undeveloped lots originally valued at $50,000 in Terralta private neighborhood development. The real property exchanged for 630 shares of Series T was recorded originally at $630,000 and reflected on the balance sheet as a long term asset for sale. The Company has actively listed the residential real property for sale since July 2021. However, based on indicator of impairment, during the year ended December 31, 2021, the Company adjusted the original value of the long term asset for sale from $630,000 to $514,000 on the balance sheet and recorded an impairment of $116,000 in the consolidated financial statements During the period ended December 31, 2022, after evaluating several offers, the Company was considering an offer for $400,000, which is $114,000 below the previously adjusted value and is indicative of the current real estate market conditions in Buenos Aires Argentina. Based on that indicator of impairment, during the year ended December 31, 2022, the Company further adjusted the previous value of the long term asset for sale from $514,000 to $400,000 on the balance sheet and recorded an impairment of $114,000 in the consolidated financial statements. The Company expects the sale to be completed in Q2, 2023. The warrants associated with Series T expired during the three months ended March 31, 2023 and as of March 31, 2023, there were no shares of Series T preferred stock issued and outstanding. Series U On May 26, 2021, the Company designated 5,000 shares of preferred stock as Series U. The Series U has a stated value of $1,000 per share. The Series U holders are not entitled to any dividends and do not have any voting rights except as may be required by applicable law. The Series U is convertible into common stock of the Company in an amount determined by dividing 150% of the stated value of the Series U being converted by the conversion price; certain prior investors will also be entitled to certain make-good shares; provided that, the Series U may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the lesser of $0.20 or the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series U at any time at a redemption price equal to, if paid in cash, the stated value, or, if paid in shares of common stock, in an amount of shares determined by dividing 200% of the stated value being redeemed by the conversion price then in effect, and adding any applicable make-good shares. As of March 31, 2023, there were 385 shares of Series U preferred stock issued and outstanding, along with 6,246,000 Series B warrants (with an exercise price of $0.25), and 1,561,500 Series C warrants (with an exercise price of $1.00) issued and outstanding with a fair value of $10.34 on the original issuance. These warrants associated with Series U were valued using the Black Scholes model (See Note 4) Series W On April 28, 2021, the Company designated 3,390 shares of preferred stock as Series W. The Series W has a stated value of $1,000 per share, and Series W holders are entitled to cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly. The Series W holders are not entitled to any voting rights except as may be required by applicable law. The Series W is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series W being converted by the conversion price; provided that, the Series W may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock. The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series W at any time at a redemption price equal to the stated value plus any accrued but unpaid dividends. As of March 31, 2023, there were 820 shares of Series W preferred stock issued and outstanding Series X On August 10, 2021, the Company designated 25 shares of preferred stock as Series X. The Series X had a stated value of $10,000 per share. The Series X holders were not entitled to any dividends and did not have any voting rights except as may have been required by applicable law. The Series X was convertible into common stock of the Company pursuant to the Series X COD, provided that, the Series X was not to be converted into common stock to the extent such conversion would have resulted in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which amount may have been increased up to 9.99% upon 61 days’ written notice). Beginning on the one year anniversary of the subscription agreement for the Series X Preferred Stock, until the two year anniversary of the subscription agreement, the holders had the right to require the Company to redeem all of the Series X purchased by the subscriber at a price equal to 125% of the $250,000 original purchase price, or $312,500. The holders also had the right, exercisable at any time, to require the Company to redeem all of the holder’s Series X in exchange for the issuance of shares of the Company’s common stock in an amount equal to 250% of the original $250,000 purchase price, or $625,000, divided by the closing price of the Company’s common stock as of the date the holders executed the subscription agreement . During the three months ended , the Company’s subsidiary, Water On Demand, Inc., executed a Secured Note Purchase Agreement upon redemption of an aggregate of 25 shares of Series X preferred stock, which had a stated value of $250,000. The shares were redeemed within the terms of the agreement and no gain or loss was recognized. As of , there were no shares of Series X preferred stock issued and outstanding Series Y On December 6, 2021, the Company designated 3,000 shares of preferred stock as Series Y. The Series Y has an original issue price of $100,000 per share, and holders are entitled to receive, on a pro rata and pari passu basis, annual distribution of up to 25% of annual net profits of newly established, wholly-owned, Water On Demand subsidiaries, designated by each holder, paid within 3 months of subsidiary’s accounting year-end. The Series Y holders are not entitled to any voting rights except as may be required by applicable law. The Series Y is convertible into common stock of the Company pursuant to the Series Y COD, provided that, the Series Y may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company has the right (but no obligation) to redeem the Series Y at any time at a redemption price equal to, if paid in cash, the original issue price plus any accrued but unpaid distributions of 25% of the subsidiary’s annual net profits. In addition, the Series Y holders are entitled to receive shares of Series A preferred stock in the Company’s subsidiary Water On Demand, Inc. During the three months ended March 31, 2023, the Company received aggregate funding in the amount of $345,000 through the sale of Series Y preferred stock Series Z On February 11, 2022, the Company designated 25 shares of preferred stock as Series Z. The Series Z has an original issue price of $10,000 per share. The Series Z holders are not entitled to dividends or any voting rights except as may be required by applicable law. The Series Z is convertible into common stock of the Company pursuant to the Series Z COD, provided that, the Series Z may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which amount may be increased up to 9.99% upon 61 days’ written notice). The Company has the right (but no obligation) to redeem the Series Z at any time at a redemption price equal to the original issue price plus any accrued but unpaid distributions of 25% of Subsidiary’s annual net profits. On February 18, 2022, the Company issued and sold to an accredited investor an aggregate of 25 shares of Series Z preferred stock for a purchase price of $250,000 and issued an aggregate of 2,500,000 warrants with a fair value of $17,594 (with an exercise price of $0.10) to Series Z holders. As of , there were 25 shares of Series Z preferred stock issued and outstanding. As of March 31, 2023, the Company accrued aggregate dividends in the amount of $418,807 for all series of preferred stock. During the three months ended March 31, 2023, the Company redeemed an aggregate of 182,145,203 shares of common stock at a price of $0.01 per share with a value of $18,214 relating to Series R and Series Y conversions and settlement agreements with certain WODI convertible secured promissory note holders. The Series J, Series L, Series M, Series O, Series P, Series Q Series R, Series S, Series T, Series U, Series V, Series W, Series X, Series Y, and Series Z preferred stock are accounted for outside of permanent equity due to the terms of conversion at a market component or stated value of the preferred stock. Water On Demand, Inc. (“WODI”) Preferred Stock On April 22, 2022, WODI designated 50,000,000 shares of authorized Preferred Stock at $0.0001 par value per share. Series A On October 13, 2022, WODI designated 1,000,000 shares of its authorized preferred stock as Series A preferred stock. The shares of Series A preferred stock are reserved for issuance to the holders of parent Company’s, OriginClear, Inc., Series Y preferred shares and issuable to the holders of the Series Y shares at a ratio of 500:1. The holders of Series A preferred shares shall not be entitled to dividends and shall not be entitled to a vote until such time as the Series A preferred shares are converted to common shares. Each share of Series A preferred stock shall be convertible, at any time at the conversion ratio of 50:1, or such other rate as determined by the Board, provided, however that at no time shall the total number of issued and outstanding Series A preferred shares, on a converted basis, be less than ten percent (10%) (‘Dilution Floor’) of the total authorized shares of common stock (on a fully diluted basis) based upon an anticipated sale of $20,000,000 in Series Y shares. The dilution floor shall be adjusted proportionately based upon the actual number of Series Y shares sold. On November 7, 2022, WODI filed an Amended and Restated Certificate of Incorporation and e

Options and Warrants

Options and Warrants	3 Months Ended
	Mar. 31, 2023
Options and Warrants [Abstract]
OPTIONS AND WARRANTS	4. OPTIONS AND WARRANTS Restricted Stock to CEO Between May 12, 2016, and January 1, 2022, the Company entered into Restricted Stock Grant Agreements (“the RSGAs”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGAs are performance based shares. The RSGAs provides for the issuance of up to an aggregate of 242,109,214 shares of the Company’s common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 121,054,607 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization Restricted Stock to the Board, Employees and Consultants Between May 12, 2016, and August 4, 2022, the Company entered into Restricted Stock Grant Agreements (“the BEC RSGAs”) with its members of the Board, employees, and consultants to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the BEC RSGAs are performance based shares. The BEC RSGAs provide for the issuance of up to 287,661,971 shares of the Company’s common stock to employees and consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 143,830,985 shares of its common stock; b) If the Company’s consolidated operating profit Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 14, 2019, the Board of Directors approved an amendment to the RSGAs and BEC RSGAs to include an alternative vesting schedule for the Grantees and on January 26, 2022, the Company amended the procedures for processing the RSGAs and BEC RSGAs. Once a Grantee is eligible to participate in alternate vesting, then they will be added to the list of alternate vestees, enlarging the pool of vestees among which, 10% of stock sales that are allowed under the agreement is divided for the next year. The Company then (i) calculates the value of the Company common stock traded in the year immediately prior to the vesting year, using daily adjusted close and volume, as quoted on the public securities trading market on which the Company’s common stock is then traded (ii) determines the cost basis of the shares, which shall be the closing price quoted on the public securities trading market, quoted on the first trading day of the vesting year which will be the grantee’s cost basis, and (iii) applies the 10% calculation and divides it into the number of qualifying alternate vestees, giving the gross number of shares available to each Grantee. For each alternate vestee for each year in which there occurs a vesting or a potential vesting, the Company (i) does a 90-day lookback from the first day of the latest vesting month, to limit cumulative vesting of shares for each alternate vestee for the 90-day period to 1% of total Company shares of common stock outstanding for the period, using the then current figure for shares outstanding at the time of the lookback; (ii) places the excess shares (the “Overlimit Shares”) in suspense for issuance in the next 90-day period so that in each future 90-day period they may be issued, and (iii) if on the 90-day lookback, cumulative issuances are less than 1% of shares outstanding, the Company will add the shares from previous 90-day lookback, if any. For the avoidance of doubt, the Company will not record any Overlimit Shares as vested until such as time as they have been finally issued. If the fair market value of the Company’s common stock on the date the shares are vested is less than the fair market value of the Company’s common stock on the effective date of the RSGA or BEC RSGA, then the number of vested shares issuable (assuming all conditions are satisfied) shall be increased so that the aggregate fair market value of vested shares issuable on the vesting date equals the aggregate fair market value that such number of shares would have had on the effective date. Upon the occurrence of a Company performance goal, the right to participate in the alternate vesting schedule will terminate, and the vesting of the remaining unvested shares will be as set forth under the restricted stock award agreement. During the three months ended March 31, 2023, per electing and qualifying under the alternative vesting schedule, the Company issued an aggregate of 2,754,073 shares of Company’s common stock relating to the RSGAs and an aggregate of 6,076,786 shares of Company’s common stock relating to the BEC RSGAs. Warrants During the three months ended March 31, 2023, the Company issued 2,680,000 purchase warrants, associated with the preferred stocks. A summary of the Company’s warrant activity and related information follows for the three months ended March 31, 2023: 3/31/2023 Number of Weighted Outstanding - beginning of period 93,344,989 $ 0.1217 Granted 2,680,000 $ 0.125 Exercised - - Expired (25,200,000 ) $ (0.05 ) Outstanding - end of period 70,824,989 $ 0. 1473 At March 31, 2023, the weighted average remaining contractual life of warrants outstanding: 2023 Weighted Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.02 600,000 600,000 3.42 $ 0.10 5,000,000 5,000,000 0.64 - 3.89 $ 0.25 10,006,000 10,006,000 0.71 - 3.75 $ 0.0275 8,727,273 8,727,273 8.16 $ 0.125 44,930,216 44,930,216 3.75 - 4.75 $ 1.00 1,561,500 1,561,500 2.25 - 2.49 70,824,989 70,824,989 The derivative liability recognized in the financial statements for the warrants as of March 31, 2023 was $1,371,892. At March 31, 2023, the aggregate intrinsic value of the warrants outstanding was $0.

Convertible Promissory Notes

Convertible Promissory Notes	3 Months Ended
	Mar. 31, 2023
Convertible Promissory Notes [Abstract]
CONVERTIBLE PROMISSORY NOTES	5. CONVERTIBLE PROMISSORY NOTES OriginClear, Inc. As of March 31, 2023, the outstanding convertible promissory notes are summarized as follows: Convertible Promissory Notes $ 2,926,755 Less current portion 2,042,983 Total long-term liabilities $ 883,772 Maturities of long-term debt for the next three years are as follows: Period Ending March 31, Amount 2023 816,008 2024 1,226,975 2025 883,772 $ 2,926,755 On various dates from November 2014 through April 2015, the Company issued unsecured convertible promissory notes (the “2014-2015 Notes”), that matured on various dates and were extended for an additional sixty (60) months from the effective date of each Note. The 2014-2015 Notes bear interest at 10% per year. The maturity dates were extended to November 2023 through April 2024. The 2014-2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes. In addition, for as long as the 2014-2015 Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the 2014-2015 Notes or such other convertible notes or a term was not similarly provided to the purchaser of the 2014-2015 Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the 2014-2015 Notes and such other convertible notes. The conversion feature of the 2014-2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2014-2015 Notes. As of March 31, 2023, the 2014-2015 Notes had an aggregate remaining balance of $774,700, which $684,700 is short term and $90,000 is long term. The unsecured convertible promissory notes (the “OID Notes”) had an aggregate remaining balance of $184,124, plus accrued interest of $13,334. The OID Notes included an original issue discount and one-time interest, which has been fully amortized. The OID Notes matured on December 31, 2017, which were extended to June 30, 2023. The OID Notes were convertible into shares of the Company’s common stock at a conversion price initially of $30,620. After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date. The conversion feature of the OID Notes was considered a derivative in accordance with current accounting guidelines, because of the reset conversion features of the OID Notes. As of March 31, 2023, the remaining balance on the OID Notes was $62,275, which is short term. The Company issued various, unsecured convertible promissory notes (the “2015 Notes”), on various dates with the last of the 2015 Notes being issued in August 2015. The 2015 Notes matured and were extended from the date of each tranche through maturity dates ending on February 2024 through March 2024, and April 2024 through August 2024. The 2015 Notes bear interest at 10% per year. The 2015 Notes are convertible into shares of the Company’s common stock at conversion prices ranging from the lesser of $1,400 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015 Notes. The conversion feature of the 2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2015 Notes. As of March 31, 2023, the 2015 Notes had an aggregate remaining balance of $1,200,000, of which $420,000 is short term and $780,000 is long term. The Company issued a convertible note (the “Dec 2015 Note”) in exchange for accounts payable in the amount of $432,048, which could be converted into shares of the Company’s common stock after December 31, 2015. The Dec 2015 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Dec 2015 Note did not meet the criteria of a derivative, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Dec 2015 Note and recognized as interest expense in the financial statements. On January 1, 2016, the Dec 2015 Note met the criteria of a derivative and was accounted for under ASC 815. The Dec 2015 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of March 31, 2023, the remaining balance on the Dec 2015 Note was $167,048, which is short term. The Company issued a convertible note (the “Sep 2016 Note”) in exchange for accounts payable in the amount of $430,896, which could be converted into shares of the Company’s common stock after September 15, 2016. The Sep 2016 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Sep 2016 Note met the criteria of a derivative and was accounted for under ASC 815. The Sep 2016 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The Sep 2016 Note did not meet the criteria of a derivative at the date of the issuance, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Sep 2016 Note and recognized as interest expense in the financial statements. The conversion feature of the Sep 2016 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Sep 2016 Note. As of March 31, 2023, the remaining balance on the Sep 2016 Note was $430,896, which is short term. The Company issued two (2) unsecured convertible promissory notes (the “Apr & May 2018 Notes”), in the aggregate amount of $300,000 on April 2, 2018 and May 31, 2018. The Apr & May 2018 Notes had maturity dates of April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per year. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty-five (25) trading days prior to conversion. The conversion feature of the Apr & May 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. On March 13, 2019, the Company entered into a settlement agreement with the investor in the amount of $570,000, based on the outstanding balance due and payable under the Apr & May 2018 Notes. The Company set up a reserve of 2,630,769 shares of common stock of the Company for issuance upon conversion by the investor of the amounts owed under the Notes, in accordance with the terms of the Notes, including, but not limited to the beneficial ownership limitations contained in the Notes. In addition to the foregoing, upon the sale by the investor of the settlement shares as delivered to the investor by the Company, resulting in total net proceeds less than the settlement value, the investor is entitled to additional settlement shares of the Company’s common stock. If after the investor has sold all settlement shares, the investor delivers a written notice to the Company certifying that the investor is entitled to additional settlement shares of the Company’s common stock (the “Make-Whole Shares”). The number of make-whole shares being equal to the greater of ((i) zero and (ii) the quotient of (1) the difference of (x) the settlement value with respect to each sale of shares by the Investor after the delivery of the Settlement Shares, minus (y) the aggregate net consideration received by the Investor from the resale of all shares of common stock issued by the Company, divided by (2) the average trailing closing price for ten (10) trading days for the shares immediately preceding the date of delivery of the make-whole shares. As of March 31, 2023, the remaining balance on the May 2018 Note was $218,064, which is short term. The Company entered into an unsecured convertible promissory note (the “Nov 20 Note”), on November 19, 2020 in the amount of $50,000. The Company received funds in the amount of $50,000. The Nov 20 Note had an original maturity date of November 19, 2021 and was extended for an additional sixty (60) months from the maturity date. The Nov 20 Note bears interest at 10% per year. The Nov 20 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Nov 20 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. As of March 31, 2023, the remaining balance on the Nov 20 Note was $13,772, which is long term. The Company entered into an unsecured convertible promissory note (the “Jan 21 Note”), on January 25, 2021 in the amount of $60,000. The Company received funds in the amount of $60,000. The Jan 21 Note had an original maturity date of January 25, 2022 and was extended for an additional sixty (60) months from the maturity date. The Jan 21 Note bears interest at 10% per year. The Jan 21 Note may be converted into shares of the Company’s common stock at a conversion price equal to the lower of (a) $0.05 per share, (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Jan 25 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $3,743 during the year ended December 31, 2022. As of March 31, 2023, the balance of the Jan 21 Note was $60,000, which is short term. We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable, so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations. The derivative liability recognized in the financial statements for the convertible promissory notes as of March 31, 2023 was $4,331,635. Water On Demand, Inc. During the period ended December 31, 2022, WODI raised capital and issued convertible secured promissory notes in the amount of $1,347,500 to investors with 10% interest per annum to acquire the equity interests in Fortune Rise Acquisition Corporation (the “SPAC”) for the purchase price of $400,000 and to pay off the promissory notes the SPAC owed to sellers. Per the terms and conditions of the convertible promissory notes, all unpaid principal, together with any unpaid and accrued interest shall be due and payable on the earlier of the twelve (12) month of the date of the Notes (the “Maturity Date”) provided, that WODI shall have the option to extend the Maturity Date for up to two (2) six-month extensions, or (ii) when, upon the occurrence and during the continuance of an event of default. During the three months ended March 31, 2023, WODI raised additional capital of $2,532,000 and an investor exchanged the Company’s Series X preferred stock in the amount of $250,000 and Series R preferred stock in the amount of $100,000 for a WODI convertible secured promissory note. Also during the period ended March 31, 2023, per settlement and conversion agreements with WODI shareholders, an aggregate of 182,145,203 shares of the Company’s common stock were redeemed at a market price of $0.01, which was added to the cash value of the shareholders’ investment to purchase WODI convertible secured promissory notes. The loss relating to these settlement and conversion agreements of $2,505,339 was accounted for in the consolidated statements of operations. As of March 31, 2023, WODI had outstanding convertible secured promissory notes in the amount of $6,734,839.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	3 Months Ended
	Mar. 31, 2023
Revenue From Contracts With Customers [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	6. REVENUE FROM CONTRACTS WITH CUSTOMERS Equipment Contracts Revenues and related costs on equipment contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. The following table represents a disaggregation of revenue by type of good or service from contracts with customers for the three months ended March 31, 2023. Three Months Ended March 31, 2023 2022 Equipment Contracts $ 926,190 $ 812,245 Component Sales 198,391 354,731 Waste Water Treatment Systems 791,075 49,460 Pump Stations 75,615 - Rental Income 6,573 6,573 Services Sales 8,550 11,096 Commission & Training - - $ 2,006,394 $ 1,234,105 Revenue recognition for other sales arrangements, such as sales for components, and service sales will remain materially consistent. Contract assets represents revenues recognized in excess of amounts billed on contracts in progress. Contract liabilities represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying balance sheets, as they will be liquidated in the normal course of the contract completion. The contract asset for the three months ended March 31, 2023 and the year ended December 31, 2022, was $1,431,791 and $1,479,491, respectively. The contract liability for the three months ended March 31, 2023 and the year ended December 31, 2022, was $916,935 and $932,458, respectively.

Financial Assets

Financial Assets	3 Months Ended
	Mar. 31, 2023
Financial Assets [Abstract]
FINANCIAL ASSETS	7. FINANCIAL ASSETS Fair value investment in Securities On November 12, 2021, the Company served a conversion notice to WTII and recorded additional interest and fees of $15,988 through that date, according to the terms of the securities purchase agreement for an aggregate of $149,867. The Note was converted into 45,208,649 shares of WTII common stock. As of March 31, 2023, the investment in securities was recorded at fair value in the amount of $22,604, with an unrealized loss of $4,521. On May 15, 2018, the Company received 4,000 shares of WTII Series C convertible preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into one thousand (1,000) shares of WTII common stock. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality was delivered immediately, the revenue was recognized in the financial statements as of June 30, 2018. As of March 31, 2023, the fair value of the preferred shares was $2,400, and had a loss in fair value of $0.

Loans Payable

Loans Payable	3 Months Ended
	Mar. 31, 2023
Loans Payable [Abstract]
LOANS PAYABLE	8. LOANS PAYABLE Secured Loans Payable The Company entered into short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. As of December 31, 2020, the finance cost was fully amortized. The term of the loans ranged from two months to six months. The net balance as of March 31, 2023 was $30,646.

Water on demand inc.

Water on demand inc.	3 Months Ended
	Mar. 31, 2023
Water on demand inc. [Abstract]
WATER ON DEMAND INC.	9. WATER ON DEMAND INC. Water On Demand, Inc. (“WODI”) was incorporated in the state of Nevada on April 22, 2022. WODI, with the support of its parent, OriginClear, Inc (the “Company”), is developing a new outsourced water treatment business called “Water On Demand”: or “WOD”. The WOD model intends to offer private businesses the ability to pay for water treatment and purification services on a per-gallon basis. This is commonly known as Design-Build-Own-Operate or “DBOO”. WODI intends to work with regional water service companies to build and operate the water treatment systems it finances. On March 23, 2022, WODI announced that it was evaluating the first pilot opportunity, a 50,000 gallon per day wastewater treatment project. On November 16, 2022, WODI filed a Form 1-A Offering Circular for an offering under Regulation A (the “Offering”) of the Securities Act of 1933 with the U.S. Securities and Exchange Commission. The purpose of the Offering is to allow potential investors the opportunity to invest directly in WODI. The Offering has a minimum investment of $1,000 and will be on a best-efforts basis. On December 22, 2022, WODI entered into a Membership Interest Purchase and Transfer Agreement (the “Purchase Agreement”) with Ka Wai Cheung, Koon Lin Chan, and Koon Keung Chan (each a “Seller”, and collectively, the “Sellers”) and Fortune Rise Sponsor LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which WODI purchased 100 membership interests in the Sponsor (“Purchased Interests”) from the Sellers, which constitutes 100% of the membership interests in the Sponsor. The Sponsor owns 2,343,750 shares out of 2,443,750 shares of the issued and outstanding shares of Class B common stock (the “Class B Common Stock”) of Fortune Rise Acquisition Corporation, a Delaware Corporation (“FRLA” or the “SPAC”). On December 29, 2022, the Company announced that its subsidiary, Water On Demand, Inc. has closed the acquisition of Fortune Rise Sponsor, LLC, which is the sponsor of Fortune Rise Acquisition Corp. On December 22, 2022, WODI paid a total of $1,137,267 to the Sellers which included a total of $400,000 to purchase the membership interest in Class B Common Stock of the SPAC and $737,267 for compensating the payment made by the Sellers on November 4, 2022, towards the first extension of the SPAC through February 5, 2023. In connection with the Extension Payment, the SPAC issued unsecured promissory notes to the Sellers. As of December 31, 2022, the $737,267 amount was reflected as Notes Payable to related party on the consolidated balance sheet of the SPAC. The SPAC is a blank check company incorporated in February 2021 as a Delaware corporation formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The SPAC is a “shell company” as defined under the Exchange Act of 1934, as amended, because it has no operations and nominal assets consisting almost entirely of cash. The SPAC will not generate any operating revenues until after the completion of its initial business combination, at the earliest. On December 29, 2022, pursuant to a Membership Interest Purchase and Transfer Agreement and Securities Transfer Agreement with the members of the Sponsor, WODI acquired the membership interests of the Sponsor and became the beneficial owner of 2,343,750 shares of Class B Common Stock of the SPAC, each of which is exercisable into one share of Class A Common Stock of the SPAC. The purchase price for the membership interests was $400,000. To acquire the equity interests in the SPAC for the purchase price of $400,000, WODI issued convertible secured promissory notes to investors at 10% interest per annum. Per the terms and conditions of the convertible promissory note, all unpaid principal, together with any unpaid and accrued interest shall be due and payable on the earlier of the twelve (12) month of the date of the Note (the “Maturity Date”) (provided, WODI shall have the option to extend the Maturity Date for up to two (2) six-month extensions, or (ii) when, upon the occurrence and during the continuance of an Event of Default. On January 5, 2023, WODI signed a non-binding Letter of Intent (the “LOI”) with Fortune Rise Acquisition Corporation, (“FRLA” collectively with WODI, the “Parties”). The LOI is not binding on the Parties and is intended solely to guide good-faith negotiations toward a definitive business combination agreement. The Parties will work together in good faith with their respective advisors to agree on a structure for the business combination that is most expedient to the consummation of the acquisition, which may result in a new (merged) entity. Pursuant to the LOI, if a business combination were to be consummated and approved, all of the outstanding equity securities of WODI, including all shares of common stock, preferred stock, outstanding options and warrants will convert into new equity of the merged entity. WODI also assumed the obligation to make any necessary extension payments in connection with the extension of the period of time in which the SPAC may consummate its initial business combination as described in the SPAC’s S-1 Registration Statement, including the three-month extension from November 5, 2022 to February 5, 2023, the second extension for an additional three months from February 5, 2023 to May 5, 2023 and a final extension for an additional six months from May 5, 2023 to November 5, 2023. On February 7, 2023, FRLA and OriginClear Inc. announced that WODI deposited $977,500 (the “Second Extension Payment”) into the Company’s trust account for its public shareholders, representing $0.10 per public share, which enables FRLA to extend the period of time it has to consummate its initial business combination by an additional three months from February 5, 2023 to May 5, 2023 (the “Second Extension”). On April 10, 2023, at the Special Meeting, a total of 10,514,410 (or 81.61%) of the Company’s issued and outstanding shares of Class A common stock and Class B common stock held of record as of March 3, 2023, were present either in person or by proxy, which constituted a quorum. In that FRLA shareholders agreed to a final extension of the period of time it has to consummate its initial business combination by an additional six months from May 5, 2023 to November 5, 2023. FRLA’s stockholders voted on to approve and adopt the extension amendment which received sufficient votes (more than 65%) for approval. On April 14, 2023, WODI entered into an Asset Purchase Agreement with the Company, whereby it agreed to purchase all of the assets related to the Company’s “Modular Water Service” business, including licenses, technology, intellectual property, contracts, business models, patents and other assets in exchange for 6,000,000 shares of WODI common stock. The assets include an assignment of OriginClear’s existing global master license to the five patents of inventor Daniel M. Early, P.E., who heads Modular Water, and the right to file patents for all additional inventions since 2018, when OriginClear created the unit. Accounting of Class B Common Founder Shares as at December 31, 2022 The Company retained an independent valuation firm for the purpose of conducting a valuation of the fair value of Sponsor Founder Shares (Class B) of FRLA as of December 31, 2022 (the “Date of Valuation”). The independent firm (i) evaluated and analyzed various Sponsor Founder Shares of FRLA; (ii) assessed the terms including various redemption and liquidation features considering each of FRLA’s financial plans and market conditions; and (iii) determined the underlying value to be assigned to the FRLA Sponsor Founder Shares as of the Date of Valuation and evaluated the FRLA Sponsor Founder Shares for impairment by performing the following procedures: ● Analyzed agreements and other documentation. ● Developed Monte Carlo Model that values the FRLA Sponsor Founder Shares based on a multipath random event model and future projections of the various potential outcomes and completed 50,000 iterations for each valuation. ● Valued the FRLA Sponsor Founder Shares as of the Date of Valuation. Based on the procedures performed the independent valuation firm concluded that the value of FRLA Sponsor Founder Shares was not impaired. Recording of membership interest: As of December 31, 2022, WODI recorded the purchase of Class B Founder Shares at lower of cost or market at $400,000 on the consolidated balance sheet as other asset. Impairment of receivable: As of December 31, 2022, the amount of $737,267 paid to compensate the Sellers (sponsors) towards the first extension of the SPAC through February 5, 2023 and which was reflected as Notes Payable to related party on the consolidated balance sheet of the SPAC, was initially recorded as a receivable by WODI. However, since the likelihood of the merger of WODI into the SPAC is estimated at 50%, the repayment of the amount is deemed not probable as the SPAC may not have the funds to pay all of the A class investors back with interest if a merger is not consummated. Therefore, as of December 31, 2022, WODI considered the amount impaired and recorded it as an expense on the consolidated income statements. Promissory Notes During the three months ended March 31, 2023, WODI and the Company received an aggregate of $1,657,920 in unsecured promissory notes (the “SPAC Notes”) from the SPAC for various payments made by WODI on behalf of the SPAC to meet its operating expenses and the extension payments. The SPAC Notes are non-interest bearing and payable (subject to the waiver against SPAC trust provisions) on the earlier of (i) consummation of the SPAC initial business combination; and (ii) the date of the liquidation of the SPAC. The principal balance of each SPAC Note may be prepaid at any time, at the election of the SPAC. Since buying the sponsorship interest in the SPAC on December 22, 2022, WODI has made payments on behalf of the SPAC in the aggregate amount of $ 2,395,187. Management continues to estimate the likelihood of the merger at 50%. Therefore it is deemed probable that the SPAC may not have funds to pay all of the Class A shareholders back with interest and WODI for the monies advanced to the SPAC, if a merger is not consummated. Therefore, although the payments made on behalf of the SPAC are monies receivable to WODI, similar to the period ended December 31, 2022, where WODI expensed the extension payment of $737,267, instead of recording it as a receivable; for the period ended March 31, 2023, WODI considered the aggregate amount of $ 1,657,920 for the notes to be impaired as well and recorded it as an expense on the consolidated income statements. In the event of WODI successfully merging with the SPAC, all monies paid by WODI on behalf of the SPAC, including any future payments made until such merger is fully consummated will be received back by WODI. Restricted Stock to WODI Board, Employees and Consultants Between August 12, 2022, and March 30, 2023, WODI entered into Restricted Stock Grant Agreements (the “WODI RSGAs”) with its members of the Board, employees, and consultants to create management incentives to improve the economic performance of WODI and to increase its value. WODI RSGAs provide for the issuance of up to 10,100,000 shares of WODI common stock provided certain milestones and vesting are met in certain stages. . WODI has not recognized any costs associated the WODI RSGAs because milestones and vesting have not been achieved. As the milestones are achieved, the shares shall become eligible for vesting and issuance.

Line of Credit

Line of Credit	3 Months Ended
	Mar. 31, 2023
Line of Credit [Abstract]
LINE OF CREDIT	10. LINE OF CREDIT During the three months ended March 31, 2023, the Company obtained a line of credit in the amount of $200,000 for one year, with an interest rate of 26.07%. No interest accrued or was due until April 2023.

Assets Held for Sale

Assets Held for Sale	3 Months Ended
	Mar. 31, 2023
Assets Held For Sale [Abstract]
ASSETS HELD FOR SALE	11. ASSETS HELD FOR SALE The Company acquired real estate assets to be held for sale to finance their water projects, by issuing 630 shares of Series T preferred stock for a fair value of $630,000, in conjunction with common stock purchase warrants, through an asset purchase agreement. The assets held for sale consisted of residential property, plus eight (8) lots of undeveloped land. The real property has been listed actively on the market to be sold. Based on the offers received and the market conditions, the Company adjusted the fair value and recognized a loss on impairment of the residential property in the amount of $230,000. As of March 31, 2023, the carrying value of the property is $400,000.

Employee Retention Tax Credit

Employee Retention Tax Credit	3 Months Ended
	Mar. 31, 2023
Employee Retention Tax Credit [Abstract]
EMPLOYEE RETENTION TAX CREDIT	12. EMPLOYEE RETENTION TAX CREDIT Under the provisions of the extension of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) passed by the United States Congress and signed by the President, the Company was eligible for a refundable employee retention credit (the “ERTC”) subject to certain criteria. The Company’s subsidiary, Progressive Water Treatment applied for the ERTC and during the three months ended March 31, 2023, received an aggregate of $126,879 which was recognized in the financial statements as other income.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	13. COMMITMENTS AND CONTINGENCIES Facility Rental – Related Party Our Dallas based subsidiary, PWT, rents an approximately 12,000 square foot facility located at 2535 E. University Drive, McKinney, TX 75069, with a current monthly rent of $8,150. Warranty Reserve Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company has various insurance policies relating to the guarantee of completed work, which in the opinion of management will adequately cover any potential claims. A warranty reserve has been provided under PWT based on the opinion of management and based on Company history in the amount of $20,000 for three months ended March 31, 2023 and the year ending December 31, 2022. Litigation There are no material updates to the litigation matters with C6 Capital, LLC nor Auctus Fund, LLC as previously disclosed in the Form 10-K filed on April 17, 2023.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	14. SUBSEQUENT EVENTS Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events: On April 14, 2023, WODI entered into an Asset Purchase Agreement with the Company, whereby it agreed to purchase all of the assets related to the Company’s “Modular Water Service” business, including licenses, technology, intellectual property, contracts, business models, patents and other assets in exchange for 6,000,000 shares of WODI common stock. The assets include an assignment of OriginClear’s existing global master license to the five patents of inventor Daniel M. Early, P.E., who heads Modular Water, and the right to file patents for all additional inventions since 2018, when OriginClear created the unit. On April 18, 2023, holders of convertible promissory notes converted an aggregate principal and interest amount of $167,365 into a total of 55,788,402 shares of the Company’s common stock. On April 25, 2023, holders of the Company’s Series Y preferred stock converted an aggregate of 2.5 Series Y shares into an aggregate of 40,841,585 shares of the Company’s common stock. Between April 25, 2023 and May 2, 2023 On April 25, 2023, per electing and qualifying for the Restricted Stock Grant Agreement alternate vesting schedule, the Company issued to an employee an aggregate of 2,754,073 shares of the Company’s common stock. Between April 26, 2023 and April 28, 2023, an aggregate of 40,841,585 shares of common stock were redeemed by the Company, and the redemption amount, together with cash paid by the redeeming stockholders, were used by the stockholders to purchase convertible secured promissory notes from WODI. On April 28, 2023, the Company filed a certificate of designation for its WODI subsidiary for Series B Preferred Stock with the Secretary of State of Nevada. Pursuant to the certificate of designation, WODI designated 1,000,000 shares of preferred stock as Series B Preferred Stock. The Series B Preferred Stock has an initial issuance value of $5.00 per share and will be convertible into common stock of WODI per terms of the certificate of designation.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	3 Months Ended
	Mar. 31, 2023
Basis of Presentation [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., Water on Demand Inc., Water On Demand1, Inc., Water On Demand2, Inc., Water On Demand3, Inc. and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities. As of March 31, 2023, the Company reorganized Water On Demand2, Inc. and Water On Demand3, Inc and combined the subsidiaries into Water On Demand1, Inc.
Cash and Cash Equivalent	Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. During the reorganization of Water On Demand1, Inc., Water On Demand2, Inc., and Water On Demand3, Inc., the restricted cash balance on the financial statements as of December 31, 2022 was combined with the overall cash balance of the consolidated Company during the three months ended March 31, 2023.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Net Earnings (Loss) per Share Calculations	Net Earnings (Loss) per Share Calculations Basic loss per share calculation is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similarly to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted earnings per share were not the same as the basic loss per share for the three months ended March 31, 2023 and 2022, respectively, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. For the Three Months 2023 2022 Loss to common shareholders (Numerator) $ (2,201,253 ) $ (3,576,267 ) Basic weighted average number of common shares outstanding (Denominator) 1,062,100,064 416,397,236 Diluted weighted average number of common shares outstanding (Denominator) 1,062,100,064 416,397,236 The Company excludes issuable shares from warrants, convertible notes and preferred stock, if their impact on the loss per share is anti-dilutive and includes the issuable shares if their impact is dilutive.
Revenue Recognition	Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.
Contract Receivable	Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was $17,315 and $17,315 as of March 31, 2023 and December 31, 2022, respectively. The net contract receivable balance was $2,132,326 and $2,479,123 at March 31, 2023 and December 31, 2022, respectively.
Indefinite Lived Intangibles and Goodwill Assets	Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill at March 31, 2023 and 2022, respectively, and determined there was no impairment of indefinite lived intangibles and goodwill.
Prepaid Expenses	Prepaid Expenses The Company records expenditures that have been paid in advance as prepaid expenses. The prepaid expenses are initially recorded as assets, because they have future economic benefits, and are expensed at the time the benefits are realized. The prepaid expenses balance was $11,372 and $25,000 at March 31, 2023 and December 31, 2022, respectively.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years 3/31/2023 12/31/22 Machinery and Equipment $ 383,569 $ 383,569 Computer Equipment 66,493 66,493 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 607,012 607,012 Less accumulated depreciation (437,771 ) (429,943 ) Net Property and Equipment $ 169,241 $ 177,069 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that the facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the three months ended March 31, 2023 and 2022, was $7,829 and $10,733, respectively.
Other Assets	Other Assets Long Term Asset Held for Sale On March 1, 2021, the Company issued an aggregate of 630 shares of Series T Preferred Stock to an accredited investor (the “Purchaser’’) per terms of a Securities Purchase Agreement (the “SPA”). Per the SPA, the Company agreed to sell to Purchaser, and Purchaser agreed to purchase from the Company, 630 shares of the Company’s Series T, and two-year cashless warrants to acquire 25,200,000 shares of the Company’s common stock, valued at $0.05 per share per terms of the SPA, which may be exercised at any time in whole or in part. The purchaser and the Company agreed that in lieu of the purchase price for the Series T, the Purchaser transferred to the Company real property, with an aggregate value agreed to be $630,000 based on an appraisal from an international independent company. The real property consists of residential real estate in Buenos Aires Argentina valued at $580,000, and eight undeveloped lots valued at $50,000 in Terralta private neighborhood development. The real property exchanged for 630 shares of Series T was recorded at $630,000 and reflected on the balance sheet as a long term asset for sale. The Company has actively listed the residential real property for sale since July 2021. However, based on indicator of impairment, during the year ended December 31, 2021, the Company adjusted the original value of the long term asset for sale from $630,000 to $514,000 on the balance sheet and recorded an impairment of $116,000 in the consolidated financial statements Throughout the year 2022, the Company continued its efforts to sell the residential real property and after evaluating several offers, it is now actively pursuing an offer for $400,000, which is $114,000 below the previously adjusted value and is indicative of the current real estate market conditions in Buenos Aires, Argentina. Based on that indicator of impairment, during the year ended December 31, 2022, the Company further adjusted the previous value of the long term asset for sale from $514,000 to $400,000 on the balance sheet and recorded an impairment of $114,000 in the consolidated financial statements.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants vest immediately and the total stock-based compensation charge is recorded in the period of the measurement date.
Accounting for Derivatives	Accounting for Derivatives The Company evaluates all its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether or not to recognized in the balance sheet, where it is practicable to estimate that value. As of March 31, 2023, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of March 31, 2023. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, March 31, 2023 $ 25,004 $ 25,004 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, March 31, 2023 $ 5,703,527 $ - $ - $ 5,703,527 The derivative liabilities consist of $4,331,635 for convertible notes outstanding and $1,371,892 for warrants outstanding for an aggregate of $5,703,527. The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of December 31, 2022 $ 9,578,904 Net loss on conversion of debt and change in derivative liabilities (3,875,377 ) Balance as of March 31, 2023 $ 5,703,527 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 3/31/2023 Risk free interest rate 4.64% - 4.97% Stock volatility factor 7.02% - 152.0% Weighted average expected option life 6 mos - 5 yrs Expected dividend yield None
Segment Reporting	Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.
Marketable Securities	Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income.
Licensing agreement	Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered.
Reclassification	Reclassification Certain amounts in the prior period financial statements have been reclassified to conform to the presentation used in the current financial statements for comparative purpose. There was no material effect on the Company’s previously issued financial statements.
Work-in-Process	Work-in-Process The Company recognizes as an asset the accumulated costs for work-in-process on projects expected to be delivered to customers. Work in Process includes the cost price of materials and labor related to the construction of equipment to be sold to customers.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Polices (Tables)	3 Months Ended
	Mar. 31, 2023
Basis of Presentation [Abstract]
Schedule of loss per share anti-dilutive effect	For the Three Months 2023 2022 Loss to common shareholders (Numerator) $ (2,201,253 ) $ (3,576,267 ) Basic weighted average number of common shares outstanding (Denominator) 1,062,100,064 416,397,236 Diluted weighted average number of common shares outstanding (Denominator) 1,062,100,064 416,397,236
Schedule of Furniture and equipment are depreciated on the straight-line method	Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years
Schedule of property plant and equipment	3/31/2023 12/31/22 Machinery and Equipment $ 383,569 $ 383,569 Computer Equipment 66,493 66,493 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 607,012 607,012 Less accumulated depreciation (437,771 ) (429,943 ) Net Property and Equipment $ 169,241 $ 177,069
Schedule of level within the fair value investments and liabilities	Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, March 31, 2023 $ 25,004 $ 25,004 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, March 31, 2023 $ 5,703,527 $ - $ - $ 5,703,527
Schedule of reconciliation of the derivative liability for which level 3 inputs	Balance as of December 31, 2022 $ 9,578,904 Net loss on conversion of debt and change in derivative liabilities (3,875,377 ) Balance as of March 31, 2023 $ 5,703,527
Schedule of fair market value of derivative liability assumptions	3/31/2023 Risk free interest rate 4.64% - 4.97% Stock volatility factor 7.02% - 152.0% Weighted average expected option life 6 mos - 5 yrs Expected dividend yield None

Options and Warrants (Tables)

Options and Warrants (Tables)	3 Months Ended
	Mar. 31, 2023
Options and Warrants [Abstract]
Schedule of warrant activity	3/31/2023 Number of Weighted Outstanding - beginning of period 93,344,989 $ 0.1217 Granted 2,680,000 $ 0.125 Exercised - - Expired (25,200,000 ) $ (0.05 ) Outstanding - end of period 70,824,989 $ 0. 1473
Schedule of weighted average remaining contractual life of warrants outstanding	2023 Weighted Remaining Exercisable Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) $ 0.02 600,000 600,000 3.42 $ 0.10 5,000,000 5,000,000 0.64 - 3.89 $ 0.25 10,006,000 10,006,000 0.71 - 3.75 $ 0.0275 8,727,273 8,727,273 8.16 $ 0.125 44,930,216 44,930,216 3.75 - 4.75 $ 1.00 1,561,500 1,561,500 2.25 - 2.49 70,824,989 70,824,989

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	3 Months Ended
	Mar. 31, 2023
Convertible Promissory Notes [Abstract]
Schedule of outstanding convertible promissory notes	Convertible Promissory Notes $ 2,926,755 Less current portion 2,042,983 Total long-term liabilities $ 883,772
Schedule of maturities of long-term debt	Period Ending March 31, Amount 2023 816,008 2024 1,226,975 2025 883,772 $ 2,926,755

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	3 Months Ended
	Mar. 31, 2023
Revenue From Contracts With Customers [Abstract]
Schedule of good or service from contracts with customers	Three Months Ended March 31, 2023 2022 Equipment Contracts $ 926,190 $ 812,245 Component Sales 198,391 354,731 Waste Water Treatment Systems 791,075 49,460 Pump Stations 75,615 - Rental Income 6,573 6,573 Services Sales 8,550 11,096 Commission & Training - - $ 2,006,394 $ 1,234,105

Basis of Presentation (Details)

Basis of Presentation (Details)	3 Months Ended
	Mar. 31, 2023 USD ($)
Basis of Presentation [Abstract]
Capital amount	$ 345,000
Generated revenue	$ 2,006,394

Summary of Significant Accoun_3

Summary of Significant Accounting Polices (Details) - USD ($)		3 Months Ended		12 Months Ended
	Mar. 01, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Feb. 24, 2021
Summary of Significant Accounting Polices (Details) [Line Items]
Allowance for doubtful accounts		$ 17,315		$ 17,315
Net contract receivable		2,132,326
Prepaid expenses		11,372		$ 25,000
Depreciation expense		$ 7,829	$ 10,733
Common stock, per share (in Dollars per share)		$ 0.0001		$ 0.0001
International independent company	$ 630,000
Real estate property value	580,000
Private development	$ 50,000
Real property share (in Shares)	630
Real property exchanged	$ 630,000
Long term asset		$ 400,000		$ 400,000
Impairment				114,000	$ 116,000
Derivative term of contract		12 months
Derivative liabilities		$ 4,331,635
Warrants outstanding		1,371,892
Aggregate derivative liabilities		$ 5,703,527
Warrant [Member]
Summary of Significant Accounting Polices (Details) [Line Items]
Acquire share (in Shares)	25,200,000
Common Stock [Member]
Summary of Significant Accounting Polices (Details) [Line Items]
Common stock, per share (in Dollars per share)	$ 0.05
Maximum [Member]
Summary of Significant Accounting Polices (Details) [Line Items]
Real estate property value				400,000
Long term asset					630,000
Long term asset				514,000
Minimum [Member]
Summary of Significant Accounting Polices (Details) [Line Items]
Real estate property value				114,000
Long term asset					514,000
Long term asset				$ 400,000
Series T Preferred Stock [Member]
Summary of Significant Accounting Polices (Details) [Line Items]
Issued an aggregate (in Shares)	630
Purchaser agreed to purchase (in Shares)	630
Common stock, per share (in Dollars per share)	$ 0.05
Long term asset						$ 630,000
Series T Preferred Stock [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) [Line Items]
Long term asset					630,000
Series T Preferred Stock [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) [Line Items]
Long term asset					$ 514,000

Summary of Significant Accoun_4

Summary of Significant Accounting Polices (Details) - Schedule of loss per share anti-dilutive effect - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Schedule of Loss Per Share Anti Dilutive Effect [Abstract]
Loss to common shareholders (Numerator) (in Dollars)	$ (2,201,253)	$ (3,576,267)
Basic weighted average number of common shares outstanding (Denominator)	1,062,100,064	416,397,236
Diluted weighted average number of common shares outstanding (Denominator)	1,062,100,064	416,397,236

Summary of Significant Accoun_5

Summary of Significant Accounting Polices (Details) - Schedule of Furniture and equipment are depreciated on the straight-line method	Dec. 31, 2022
Machinery and equipment [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of Furniture and equipment are depreciated on the straight-line method [Line Items]
Estimated Life	5 years
Machinery and equipment [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of Furniture and equipment are depreciated on the straight-line method [Line Items]
Estimated Life	10 years
Furniture, fixtures and computer equipment [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of Furniture and equipment are depreciated on the straight-line method [Line Items]
Estimated Life	5 years
Furniture, fixtures and computer equipment [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of Furniture and equipment are depreciated on the straight-line method [Line Items]
Estimated Life	7 years
Vehicles [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of Furniture and equipment are depreciated on the straight-line method [Line Items]
Estimated Life	3 years
Vehicles [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of Furniture and equipment are depreciated on the straight-line method [Line Items]
Estimated Life	5 years
Leasehold improvements [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of Furniture and equipment are depreciated on the straight-line method [Line Items]
Estimated Life	2 years
Leasehold improvements [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of Furniture and equipment are depreciated on the straight-line method [Line Items]
Estimated Life	5 years

Summary of Significant Accoun_6

Summary of Significant Accounting Polices (Details) - Schedule of property plant and equipment - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	$ 607,012	$ 607,012
Less accumulated depreciation	(437,771)	(429,943)
Net Property and Equipment	169,241	177,069
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	383,569	383,569
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	66,493	66,493
Furniture [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	29,810	29,810
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	26,725	26,725
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	64,276	64,276
Demo Units [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	$ 36,139	$ 36,139

Summary of Significant Accoun_7

Summary of Significant Accounting Polices (Details) - Schedule of level within the fair value investments and liabilities	Mar. 31, 2023 USD ($)
Summary of Significant Accounting Polices (Details) - Schedule of level within the fair value investments and liabilities [Line Items]
Investment at fair value-securities	$ 25,004
Derivative Liability	5,703,527
Level 1 [Member]
Summary of Significant Accounting Polices (Details) - Schedule of level within the fair value investments and liabilities [Line Items]
Investment at fair value-securities	25,004
Derivative Liability
Level 2 [Member]
Summary of Significant Accounting Polices (Details) - Schedule of level within the fair value investments and liabilities [Line Items]
Investment at fair value-securities
Derivative Liability
Level 3 [Member]
Summary of Significant Accounting Polices (Details) - Schedule of level within the fair value investments and liabilities [Line Items]
Investment at fair value-securities
Derivative Liability	$ 5,703,527

Summary of Significant Accoun_8

Summary of Significant Accounting Polices (Details) - Schedule of reconciliation of the derivative liability for which level 3 inputs	3 Months Ended
	Mar. 31, 2023 USD ($)
Schedule of Reconciliation of the Derivative Liability for Which Level 3 Inputs [Abstract]
Balance at beginning	$ 9,578,904
Net loss on conversion of debt and change in derivative liabilities	(3,875,377)
Balance at ending	$ 5,703,527

Summary of Significant Accoun_9

Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions	3 Months Ended
	Mar. 31, 2023
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Expected dividend yield	0%
Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Risk free interest rate	4.64%
Stock volatility factor	7.02%
Weighted average expected option life	6 months
Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Risk free interest rate	4.97%
Stock volatility factor	152%
Weighted average expected option life	5 years

Capital Stock (Details)

Capital Stock (Details)

1 Months Ended

3 Months Ended

12 Months Ended

May 02, 2023 USD ($)

Nov. 07, 2022

Oct. 20, 2022 $ / shares shares

Oct. 13, 2022 shares

Apr. 22, 2022 USD ($) $ / shares shares

Feb. 11, 2022 USD ($) shares

Jan. 25, 2022 shares

Dec. 06, 2021 USD ($) shares

Dec. 01, 2021

Nov. 12, 2021 USD ($)

Aug. 10, 2021 USD ($) $ / shares shares

May 26, 2021 $ / shares shares

Apr. 30, 2021 USD ($)

Apr. 28, 2021 $ / shares shares

Mar. 01, 2021 USD ($) $ / shares shares

Feb. 24, 2021 USD ($) $ / shares shares

Feb. 05, 2021 $ / shares shares

Nov. 16, 2020 $ / shares shares

Sep. 01, 2020 USD ($)

Aug. 21, 2020 $ / shares shares

Jul. 01, 2020 USD ($) $ / shares shares

Apr. 27, 2020 $ / shares shares

Jun. 03, 2019 $ / shares shares

Apr. 03, 2019 $ / shares shares

Jan. 16, 2019 USD ($) $ / shares shares

Aug. 14, 2018 $ / shares shares

Apr. 13, 2018 $ / shares shares

Mar. 14, 2017 $ / shares shares

Feb. 18, 2022 USD ($) $ / shares shares

Mar. 31, 2023 USD ($) $ / shares shares

Mar. 31, 2022 USD ($) $ / shares shares

Dec. 31, 2022 USD ($) $ / shares shares

Dec. 31, 2021 USD ($) shares

Jun. 10, 2021 shares

May 15, 2018 $ / shares

Capital Stock (Details) [Line Items]

Shares issued

10,100,000

Aggregate preferred stock, share issued

25

Common stock par value (in Dollars per share) | $ / shares

$ 0.0001

$ 0.0001

Fair value of original issuance (in Dollars) | $

$ 1,371,892

Fair value (in Dollars) | $

630,000

Price per share (in Dollars per share) | $ / shares

$ 0.0075

Common stock value (in Dollars) | $

111,895

$ 101,337

Financing received (in Dollars) | $

130,584

Common stock issued for services, shares

13,314,289

Common stock issued for services fair value (in Dollars) | $

$ 338,724

Fair value (in Dollars) | $

$ 8,584

$ 11,101

Common stock, shares Issued

1,118,939,374

1,013,369,185

Conversion of preferred shares

875,000

Aggregate principal amount (in Dollars) | $

$ 149,867

Warrants description

The Company issued 1,000,000 shares of common stock upon exercise of 1,000,000 warrants at an exercise price of $0.05 per share for $50,000. The Company issued 1,798,562 shares of common stock at a price of $0.0695 in conjunction with the sale of Series X preferred stock and recognized a loss of $125,000 in the financial statements.

Series I Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Aggregate of value (in Dollars) | $

$ 25,000

Common Stock [Member]

Capital Stock (Details) [Line Items]

Shares outstanding

1,118,939,374

526,305,492

1,013,369,185

306,883,932

Common stock par value (in Dollars per share) | $ / shares

$ 0.05

Aggregate of shares

182,145,203

Aggregate stock redeemed

182,145,203

Price per share (in Dollars per share) | $ / shares

$ 0.01

Shares issued

85,836,889

111,010,481

Common stock of convertible promissory notes

18,645,028

Aggregate principal amount (in Dollars) | $

$ 130,584

Interest amount (in Dollars) | $

$ 49,734

Conversion price (in Dollars per share) | $ / shares

$ 0.00955

Common stock issued for services, shares

23,716,123

Common stock issued for services fair value (in Dollars) | $

$ 253,210

Redeemed Common stock value (in Dollars) | $

$ 18,214

Common stock share issued

12,461,909

Aggregate principal amount (in Dollars) | $

$ 69,900

Aggregate purchase price (in Dollars) | $

$ 119,634

Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Shares outstanding

32,502,677

33,038,213

32,502,475

33,038,213

Series Y Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Warrants shares (in Dollars) | $

$ 48,410,216

Water On Demand, Inc. (‘WODI’) Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Designated preferred stock issued

50,000,000

Preferred stock per share (in Dollars per share) | $ / shares

$ 0.0001

OriginClear, Inc. Common Stock [Member]

Capital Stock (Details) [Line Items]

Common stock par value (in Dollars per share) | $ / shares

$ 0.0001

Shares issued

25,000,000

Maximum [Member]

Capital Stock (Details) [Line Items]

Long term asset for sale (in Dollars) | $

$ 514,000

Conversion price (in Dollars per share) | $ / shares

$ 0.0319

Share prices ranging (in Dollars per share) | $ / shares

$ 0.0051

Maximum [Member] | Common Stock [Member]

Capital Stock (Details) [Line Items]

Conversion price (in Dollars per share) | $ / shares

$ 0.00816

Minimum [Member]

Capital Stock (Details) [Line Items]

Long term asset for sale (in Dollars) | $

$ 400,000

Interest amount (in Dollars) | $

$ 0.0064

Conversion price (in Dollars per share) | $ / shares

$ 0.0235

Share prices ranging (in Dollars per share) | $ / shares

$ 0.0135

Series C Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock per share (in Dollars per share) | $ / shares

$ 0.0001

Voting power

51%

Purchase price of the series C preferred stock (in Dollars per share) | $ / shares

$ 0.1

Total purchase price series C preferred stock, shares

1,000

Preferred stock, shares issued

1,001,000

1,001,000

Preferred stock, shares outstanding

1,001,000

1,001,000

Preferred stock, description

the Board of Directors authorized the issuance of 1,000,000 shares of Series C preferred stock, par value $0.0001 per share, to T. Riggs Eckelberry (the “Holder”) in exchange for his continued employment with the Company. The Holder of Series C preferred stock is not entitled to receive dividends, is not entitled to any liquidation preference and shares of Series C preferred stock does not have any conversion rights. The Holder of Series C preferred shares shall vote with the holders of the common shares on an as converted basis. However, as long as any shares of Series C preferred shares are outstanding, the Company shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Series C preferred shares directly and/or indirectly (a) alter or change adversely the powers, preferences or rights given to the Series C preferred shares or alter or amend this Certificate of Designation, (b) amend its Articles of Incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (c) increase the number of authorized shares of Series C preferred shares, or (d) enter into any agreement with respect to any of the foregoing. Notwithstanding the foregoing, the Holder shall be entitled to vote a number of shares equal to fifty-one percent (51%) of the total number of voting shares. As of March 31, 2023, there were 1,000,000 shares of Series C preferred stock outstanding with a value of $100, held by Mr. Eckelberry.

Series D-1 Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock, shares issued

31,500,000

31,500,000

Preferred stock, share authorized

50,000,000

Convertible preferred stock, per share (in Dollars per share) | $ / shares

$ 0.0005

Percentage of common stock outstanding

4.99%

Increased common stock percentage

9.99%

Preferred stock, shares outstanding

31,500,000

31,500,000

Series E Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock, share authorized

4,000,000

Convertible preferred stock, per share (in Dollars per share) | $ / shares

$ 0.05

Percentage of common stock outstanding

4.99%

Increased common stock percentage

9.99%

Conversion shares

1,537,213

Series E Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Aggregate preferred stock, share issued

76,865

Series F Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock, shares issued

60

Aggregate preferred stock, share issued

365

Designated preferred stock issued

6,000

Preferred stock liquidation per share (in Dollars per share) | $ / shares

$ 1,000

Annual rate percentage

8%

Aggregate redemption price (in Dollars) | $

$ 60,000

Series G Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock, shares issued

25

Preferred stock, shares outstanding

25

Designated preferred stock issued

6,000

Annual rate percentage

8%

Preferred stock per share (in Dollars per share) | $ / shares

$ 1,000

Divided closing price (in Dollars) | $

$ (500)

Series I Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock, shares issued

25

25

Preferred stock, shares outstanding

25

25

Preferred stock, description

the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I is not entitled to any voting rights except as may be required by applicable law, and are not convertible into common stock. The Company has the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company was required to redeem such shares of Series I between May 2, 2021 and June 10, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. The issuances of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense.

Shares outstanding

25,000

Series J Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock per share (in Dollars per share) | $ / shares

$ 1,000

Designated preferred stock issued

100,000

Preferred stock issued and outstanding

210

Series K Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock per share (in Dollars per share) | $ / shares

$ 1,000

Preferred stock, shares issued

407.15

407.15

Preferred stock, shares outstanding

407.15

407.15

Designated preferred stock issued

4,000

Aggregate redemption price (in Dollars) | $

$ 407,150

Dividend rate, percentage

8%

Series L Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock per share (in Dollars per share) | $ / shares

$ 1,000

Designated preferred stock issued

100,000

Preferred stock issued and outstanding

321

Series M Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Designated preferred stock issued

800,000

Preferred stock issued and outstanding

40,300

Dividend rate, percentage

10%

Stated value (in Dollars) | $

$ 25

Liquidation preference value (in Dollars) | $

$ 25

Redemption price, per share (in Dollars per share) | $ / shares

$ 37.5

Stated value percentage

150%

Series O Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock per share (in Dollars per share) | $ / shares

$ 1,000

Conversion shares

40

Designated preferred stock issued

2,000

Preferred stock issued and outstanding

190

Dividend rate, percentage

4%

Conversion price percentage

200%

preferred stock shares Issued (in Dollars per share) | $ / shares

$ 238,003

Common stock issued for services, shares

238,003

Series O Preferred Stock [Member] | Common Stock [Member]

Capital Stock (Details) [Line Items]

Conversion shares

7,722,008

Common stock for preferred stock dividends payable

261,707

Series O Preferred Stock [Member] | Maximum [Member]

Capital Stock (Details) [Line Items]

Annual rate percentage

8%

Outstanding common stock percentage

9.99%

Series O Preferred Stock [Member] | Minimum [Member]

Capital Stock (Details) [Line Items]

Annual rate percentage

4%

Outstanding common stock percentage

4.99%

Series P Preferred Stocks Member

Capital Stock (Details) [Line Items]

Increased common stock percentage

9.99%

Designated preferred stock issued

500

Preferred stock per share (in Dollars per share) | $ / shares

$ 1,000

Preferred stock issued and outstanding

30

Percentage of common stock

4.99%

Common stock, shares Issued

633,282

Series Q Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Percentage of common stock outstanding

4.99%

Aggregate preferred stock, share issued

25

Conversion shares

4,208,756

Designated preferred stock issued

2,000

Preferred stock per share (in Dollars per share) | $ / shares

$ 1,000

Preferred stock issued and outstanding

590

Dividend rate, percentage

12%

Percentage of common stock

200%

Common stock outstanding increased percentage

9.99%

Aggregate shares (in Dollars) | $

$ 70,652,445

Series R Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Shares issued

2,363

Percentage of common stock outstanding

4.99%

Designated preferred stock issued

5,000

Preferred stock per share (in Dollars per share) | $ / shares

$ 1,000

Dividend rate, percentage

10%

Percentage of common stock

200%

Common stock outstanding increased percentage

9.99%

Common stock value (in Dollars) | $

$ 18,214

Series R Preferred Stock [Member] | Common Stock [Member]

Capital Stock (Details) [Line Items]

Aggregate stock redeemed

182,145,203

Price per share (in Dollars per share) | $ / shares

$ 0.01

Series S Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock per share (in Dollars per share) | $ / shares

$ 1,000

Percentage of common stock outstanding

4.99%

Increased common stock percentage

9.99%

Conversion shares

4,208,756

Designated preferred stock issued

430

Preferred stock issued and outstanding

145

Dividend rate, percentage

12%

Percentage of common stock

200%

Series T Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Shares issued

630

Preferred stock per share (in Dollars per share) | $ / shares

$ 1,000

Percentage of common stock outstanding

4.99%

Designated preferred stock issued

630

Common stock outstanding increased percentage

9.99%

Common stock par value (in Dollars per share) | $ / shares

$ 0.05

Real property cost (in Dollars) | $

$ 630,000

Property consists of residential real estate (in Dollars) | $

580,000

Undeveloped lots valued (in Dollars) | $

$ 50,000

Long term asset for sale (in Dollars) | $

$ 630,000

Impairment amount (in Dollars) | $

$ 116,000

Sale of property, description

During the period ended December 31, 2022, after evaluating several offers, the Company was considering an offer for $400,000, which is $114,000 below the previously adjusted value and is indicative of the current real estate market conditions in Buenos Aires Argentina. Based on that indicator of impairment, during the year ended December 31, 2022, the Company further adjusted the previous value of the long term asset for sale from $514,000 to $400,000 on the balance sheet and recorded an impairment of $114,000 in the consolidated financial statements. The Company expects the sale to be completed in Q2, 2023. The warrants associated with Series T expired during the three months ended March 31, 2023 and as of March 31, 2023, there were no shares of Series T preferred stock issued and outstanding.

Series T Preferred Stock [Member] | Maximum [Member]

Capital Stock (Details) [Line Items]

Long term asset for sale (in Dollars) | $

630,000

Series T Preferred Stock [Member] | Minimum [Member]

Capital Stock (Details) [Line Items]

Long term asset for sale (in Dollars) | $

$ 514,000

Series U Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock, shares issued

385

Percentage of common stock outstanding

4.99%

Preferred stock, shares outstanding

385

Designated preferred stock issued

5,000

Preferred stock per share (in Dollars per share) | $ / shares

$ 1,000

Percentage of common stock

150%

Common stock outstanding increased percentage

9.99%

Common stock par value (in Dollars per share) | $ / shares

$ 0.2

Conversion price percentage

200%

Series U Preferred Stock [Member] | Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Fair value of original issuance (in Dollars) | $

$ 10.34

Series B Warrants [Member]

Capital Stock (Details) [Line Items]

Warrants shares (in Dollars) | $

$ 6,246,000

Exercise price (in Dollars per share) | $ / shares

$ 0.25

Series C warrants [Member]

Capital Stock (Details) [Line Items]

Exercise price (in Dollars per share) | $ / shares

$ 1

Warrants shares

1,561,500

Series W Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock, shares issued

820

Preferred stock, shares outstanding

820

Designated preferred stock issued

3,390

Annual rate percentage

12%

Preferred stock per share (in Dollars per share) | $ / shares

$ 1,000

Stated value percentage

200%

Outstanding common stock percentage

4.99%

Trading days

5

Series W Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Designated preferred stock issued

25

Preferred stock per share (in Dollars per share) | $ / shares

$ 10,000

Aggregate of value (in Dollars) | $

$ 250,000

Percentage of common stock

250%

Subscription agreement percentage

125%

Subscribed amount (in Dollars) | $

$ 250,000

Original purchase price (in Dollars) | $

312,500

Common stock purchase price (in Dollars) | $

250,000

Divided price (in Dollars) | $

$ 625,000

Aggregate of shares

25

Preferred stock issued and outstanding

25

Common stock, shares Issued

150,448,490

Series V Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Percentage of common stock outstanding

4.99%

Increased common stock percentage

9.99%

Aggregate of shares

63,656,525

Conversion of shares

4.2

Aggregate value of common stock

1

Series Y Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock, shares issued

36.8

Percentage of common stock outstanding

4.99%

Increased common stock percentage

9.99%

Designated preferred stock issued

3,000

Aggregate of value (in Dollars) | $

$ 345,000

Aggregate shares (in Dollars) | $

$ 40,841,585

Original issue price (in Dollars) | $

$ 100,000

Annual net profits percentage

25%

Subsidiary’s annual net profits percentage

25%

Fair value (in Dollars) | $

470,438

Amount of accrued dividends (in Dollars) | $

$ 418,807

Aggregate value of common stock

500

Sale of aggregate shares

20,000,000

Series Y Preferred Stock [Member] | Maximum [Member]

Capital Stock (Details) [Line Items]

Exercise prices per share (in Dollars per share) | $ / shares

$ 0.25

Series Y Preferred Stock [Member] | Minimum [Member]

Capital Stock (Details) [Line Items]

Exercise prices per share (in Dollars per share) | $ / shares

$ 0.13

Series Z Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Designated preferred stock issued

25

Annual rate percentage

25%

Common stock outstanding increased percentage

9.99%

Original issue price (in Dollars) | $

$ 10,000

Fair value (in Dollars) | $

$ 17,594

Exercise prices per share (in Dollars per share) | $ / shares

$ 0.1

Common stock, shares, outstanding percentage

4.99%

Aggregate shares

25

Preferred stock purchase price (in Dollars) | $

$ 250,000

Number of warrants shares

2,500,000

Series A Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock, shares issued

1,475

1,475

Preferred stock, shares outstanding

1,677

1,677

Designated preferred stock issued

1,000,000

Conversion price percentage

10%

Aggregate shares issued (in Dollars per share) | $ / shares

$ 202

Series A Preferred Stock [Member] | WODI [Member]

Capital Stock (Details) [Line Items]

Aggregate preferred stock, share issued

0.0001

Series A Preferred Stock [Member] | Maximum [Member]

Capital Stock (Details) [Line Items]

Shares ratio

50

Reverse stock split

20

Series A Preferred Stock [Member] | Minimum [Member]

Capital Stock (Details) [Line Items]

Shares ratio

1

Reverse stock split

1

Series A Preferred Stock [Member] | Capital Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock, shares issued

1,677

Board of Directors Chairman [Member] | Series C Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Shares issued

1,000

Preferred stock per share (in Dollars per share) | $ / shares

$ 0.0001

OriginClear, Inc [Member] | Series Q Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Conversion shares

100

Securities Purchase Agreement [Member] | Series T Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Aggregate purchase price, shares

630

Agreed of purchase warrants

630

Number of acquire warrant shares

25,200,000

Mr. Eckelberry [Member] | Series C Preferred Stock [Member]

Capital Stock (Details) [Line Items]

Preferred stock, shares issued

1,000

OriginClear, Inc. Common Stock [Member]

Capital Stock (Details) [Line Items]

Aggregate of shares

18,645,028

Options and Warrants (Details)

Options and Warrants (Details) - USD ($)		3 Months Ended
	Aug. 14, 2019	Mar. 31, 2023	Dec. 31, 2022
Options and Warrants (Details) [Line Items]
Restricted stock grant agreement, description		The BEC RSGAs provide for the issuance of up to 287,661,971 shares of the Company’s common stock to employees and consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 143,830,985 shares of its common stock; b) If the Company’s consolidated operating profit Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC reports, the Company will issue up to an aggregate of 143,830,985 shares of its common stock.
Board of directors amendment, description	The Company then (i) calculates the value of the Company common stock traded in the year immediately prior to the vesting year, using daily adjusted close and volume, as quoted on the public securities trading market on which the Company’s common stock is then traded (ii) determines the cost basis of the shares, which shall be the closing price quoted on the public securities trading market, quoted on the first trading day of the vesting year which will be the grantee’s cost basis, and (iii) applies the 10% calculation and divides it into the number of qualifying alternate vestees, giving the gross number of shares available to each Grantee. For each alternate vestee for each year in which there occurs a vesting or a potential vesting, the Company (i) does a 90-day lookback from the first day of the latest vesting month, to limit cumulative vesting of shares for each alternate vestee for the 90-day period to 1% of total Company shares of common stock outstanding for the period, using the then current figure for shares outstanding at the time of the lookback; (ii) places the excess shares (the “Overlimit Shares”) in suspense for issuance in the next 90-day period so that in each future 90-day period they may be issued, and (iii) if on the 90-day lookback, cumulative issuances are less than 1% of shares outstanding, the Company will add the shares from previous 90-day lookback, if any. For the avoidance of doubt, the Company will not record any Overlimit Shares as vested until such as time as they have been finally issued.
Purchase warrants issued		2,680,000
Derivative liability recognized warrants		$ 1,371,892
Warrants outstanding		$ 0	$ 0
Restricted Stock Grant Agreement [Member]
Options and Warrants (Details) [Line Items]
Aggregate shares		2,754,073
Aggregate shares issued		6,076,786
Restricted Stock Grant Agreement [Member] | Chief Executive Officer [Member]
Options and Warrants (Details) [Line Items]
Restricted stock grant agreement, description		The RSGAs provides for the issuance of up to an aggregate of 242,109,214 shares of the Company’s common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 121,054,607 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported in the Company’s SEC Reports, the Company will issue up to an aggregate of 121,054,607 shares of its common stock.
Restricted Stock Grant Agreement [Member] | Employee Consultants and Restricted Stock Grant Agreements [Member]
Options and Warrants (Details) [Line Items]
Aggregate of common stock, percentage	10%

Options and Warrants (Details)

Options and Warrants (Details) - Schedule of warrant activity	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Number of Warrants [Member]
Schedule of Warrant Activity [Abstract]
Number of Warrants, Outstanding - beginning of period | shares	93,344,989
Number of Warrants, Granted | shares	2,680,000
Number of Warrants, Exercised | shares
Number of Warrants Expired | shares	(25,200,000)
Number of Warrants, Outstanding - end of period | shares	70,824,989
Weighted average exercise price [Member]
Schedule of Warrant Activity [Abstract]
Weighted average exercise price, Outstanding - beginning of period | $ / shares	$ 0.1217
Weighted average exercise price, Granted | $ / shares	0.125
Weighted average exercise price, Exercised | $ / shares
Weighted average exercise price Expired | $ / shares	(0.05)
Weighted average exercise price, Outstanding - end of period | $ / shares	$ 0.1473

Options and Warrants (Details_2

Options and Warrants (Details) - Schedule of weighted average remaining contractual life of warrants outstanding	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Warrants Outstanding	70,824,989
Warrants Exercisable	70,824,989
0.02 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.02
Warrants Outstanding	600,000
Warrants Exercisable	600,000
Weighted Average Remaining Contractual Life (years)	3 years 5 months 1 day
0.10 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.1
Warrants Outstanding	5,000,000
Warrants Exercisable	5,000,000
0.25 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.25
Warrants Outstanding	10,006,000
Warrants Exercisable	10,006,000
0.0275 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.0275
Warrants Outstanding	8,727,273
Warrants Exercisable	8,727,273
Weighted Average Remaining Contractual Life (years)	8 years 1 month 28 days
0.125 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Exercisable Prices (in Dollars per share) | $ / shares	$ 0.125
Warrants Outstanding	44,930,216
Warrants Exercisable	44,930,216
1.00 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Exercisable Prices (in Dollars per share) | $ / shares	$ 1
Warrants Outstanding	1,561,500
Warrants Exercisable	1,561,500
Minimum [Member] | 0.10 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Weighted Average Remaining Contractual Life (years)	7 months 20 days
Minimum [Member] | 0.25 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Weighted Average Remaining Contractual Life (years)	8 months 15 days
Minimum [Member] | 0.125 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Weighted Average Remaining Contractual Life (years)	3 years 9 months
Minimum [Member] | 1.00 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Weighted Average Remaining Contractual Life (years)	2 years 3 months
Maximum [Member] | 0.10 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Weighted Average Remaining Contractual Life (years)	3 years 10 months 20 days
Maximum [Member] | 0.25 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Weighted Average Remaining Contractual Life (years)	3 years 9 months
Maximum [Member] | 0.125 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Weighted Average Remaining Contractual Life (years)	4 years 9 months
Maximum [Member] | 1.00 [Member]
Schedule of Weighted Average Remaining Contractual Life of Warrants Outstanding [Abstract]
Weighted Average Remaining Contractual Life (years)	2 years 5 months 26 days

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - USD ($)			1 Months Ended	3 Months Ended	12 Months Ended
	Mar. 13, 2019	Apr. 02, 2018	May 31, 2018	Mar. 31, 2023	Dec. 31, 2022	Jan. 25, 2021	Nov. 19, 2020	May 15, 2018
Convertible Promissory Notes (Details) [Line Items]
Aggregate amount				$ 126,879
Derivative liability				4,331,635
secured promissory notes					$ 1,347,500
Investors interest					10%
Purchase price					$ 400,000
Additional capital				2,532,000
Share Price (in Dollars per share)								$ 0.0075
Convertible promissory notes				6,734,839
Common Stock [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate amount				$ 2,505,339
Aggregate of share (in Shares)				182,145,203
Share Price (in Dollars per share)				$ 0.01
2014-2015 Notes [Member]
Convertible Promissory Notes (Details) [Line Items]
Interest rate				10%
Trade price percentage				50%
Aggregate remaining amount				$ 774,700
2014-2015 Notes [Member] | Minimum [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion into common stock				4,200
2014-2015 Notes [Member] | Maximum [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion into common stock				$ 9,800
Unsecured Convertible Promissory Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Interest rate				10%
Trade price percentage				50%
Aggregate amount		$ 300,000	$ 300,000	$ 1,200,000
Conversion price per share of debt, description				The Apr & May 2018 Notes had maturity dates of April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per year. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty-five (25) trading days prior to conversion.
Investor amount	$ 570,000
Reserved shares (in Shares)				2,630,769
Unsecured Convertible Promissory Note [Member] | Minimum [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion into common stock				$ 1,400
Unsecured Convertible Promissory Note [Member] | Maximum [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion into common stock				$ 5,600
Dec 2015 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Interest rate				0%
Nov 20 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Interest rate				10%
Trade price percentage				50%
Conversion price per share (in Dollars per share)				$ 0.05
Convertible debt received funds				$ 50,000
Penalty per day				$ 2,000
Jan 21 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Interest rate				10%
Trade price percentage				50%
Maturity date				Jan. 25, 2022
Conversion price per share (in Dollars per share)				$ 0.05
Penalty per day				$ 2,000
Short-Term Debt [Member] | 2014-2015 Notes [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				684,700
Short-Term Debt [Member] | Unsecured Convertible Promissory Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				420,000
Short-Term Debt [Member] | Dec 2015 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				167,048
Short-Term Debt [Member] | Sep 2016 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				430,896
Long-Term Debt [Member] | 2014-2015 Notes [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				90,000
Long-Term Debt [Member] | Unsecured Convertible Promissory Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				780,000
Long-Term Debt [Member] | Nov 20 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				13,772
Series X Preferred Stock [Member]
Convertible Promissory Notes (Details) [Line Items]
Preferred stock value				$ 250,000
Aggregate of share (in Shares)				25
Series R Preferred Stock [Member]
Convertible Promissory Notes (Details) [Line Items]
Preferred stock value				$ 100,000
Series R Preferred Stock [Member] | Common Stock [Member]
Convertible Promissory Notes (Details) [Line Items]
Share Price (in Dollars per share)				$ 0.01
Original Issue Discount Notes [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion into common stock				$ 30,620
Trade price percentage				50%
Aggregate remaining amount				$ 184,124
Accrued interest				$ 13,334
Maturity date				Dec. 31, 2017
Conversion price per share (in Dollars per share)				$ 5,600
Short term remaining balance				$ 62,275
Convertible Debt [Member] | Dec 2015 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Accounts payable				$ 432,048
Percentage of average of lowest sale prices				75%
Convertible Debt [Member] | Sep 2016 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Interest rate				0%
Accounts payable				$ 430,896
Percentage of average of lowest sale prices				75%
Unsecured Convertible Promissory Note [Member] | Nov 20 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Convertible debt							$ 50,000
Unsecured Convertible Promissory Note [Member] | Jan 21 Note [Member]
Convertible Promissory Notes (Details) [Line Items]
Convertible debt						$ 60,000
Convertible debt received funds				$ 60,000
Interest expense				3,743
Remaining debt amount				60,000
Unsecured Convertible Promissory Note [Member] | Short-Term Debt [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				$ 218,064

Convertible Promissory Notes _2

Convertible Promissory Notes (Details) - Schedule of outstanding convertible promissory notes	Mar. 31, 2023 USD ($)
Schedule of outstanding convertible promissory notes [Abstract]
Convertible Promissory Notes	$ 2,926,755
Less current portion	2,042,983
Total long-term liabilities	$ 883,772

Convertible Promissory Notes _3

Convertible Promissory Notes (Details) - Schedule of maturities of long-term debt	Mar. 31, 2023 USD ($)
Schedule of maturities of long term debt [Abstract]
2023	$ 816,008
2024	1,226,975
2025	883,772
Total	$ 2,926,755

Revenue from Contracts with C_3

Revenue from Contracts with Customers (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Revenue From Contracts With Customers [Abstract]
Contract asset	$ 1,431,791	$ 1,479,491
Contract liability	$ 916,935	$ 932,458

Revenue from Contracts with C_4

Revenue from Contracts with Customers (Details) - Schedule of good or service from contracts with customers - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Schedule of Good or Service From Contracts With Customers [Abstract]
Equipment Contracts	$ 926,190	$ 812,245
Component Sales	198,391	354,731
Waste Water Treatment Systems	791,075	49,460
Pump Stations	75,615
Rental Income	6,573	6,573
Services Sales	8,550	11,096
Commission & Training
Total	$ 2,006,394	$ 1,234,105

Financial Assets (Details)

Financial Assets (Details) - USD ($)			3 Months Ended
	Nov. 12, 2021	May 15, 2018	Mar. 31, 2023	Mar. 31, 2022
Financial Assets (Details) [Line Items]
Interest and fees	$ 15,988
Aggregate amount	$ 149,867
Converted common stock (in Shares)	45,208,649
Investment in securities in fair value amount			$ 22,604
Unrealized gain			4,521
Fair market value (in Dollars per share)		$ 0.0075
Share price amount		$ 30,000
Preferred shares fair value			2,400
Fair value loss			$ 0
Common Stock [Member]
Financial Assets (Details) [Line Items]
Aggregate amount				$ 69,900
Fair market value (in Dollars per share)			$ 0.01
Series C Convertible Preferred Stock [Member]
Financial Assets (Details) [Line Items]
Convertible preferred stock (in Shares)		4,000
Series C Convertible Preferred Stock [Member] | Common Stock [Member]
Financial Assets (Details) [Line Items]
Convertible preferred stock (in Shares)		(1,000)

Loans Payable (Details)

Loans Payable (Details)	3 Months Ended
	Mar. 31, 2023 USD ($)
Loans Payable (Details) [Line Items]
Net balance	$ 30,646
Secured Loans Payable [Member]
Loans Payable (Details) [Line Items]
Secured loans payable, description	The Company entered into short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. As of December 31, 2020, the finance cost was fully amortized. The term of the loans ranged from two months to six months.

Water on demand inc. (Details)

Water on demand inc. (Details) - USD ($)		1 Months Ended				3 Months Ended		12 Months Ended
	Apr. 10, 2023	Dec. 31, 2022	Dec. 29, 2022	Dec. 22, 2022	Mar. 23, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Apr. 14, 2023	Feb. 07, 2023	Nov. 16, 2022
Water on demand inc. (Details) [Line Items]
Water on demand, inc description					On March 23, 2022, WODI announced that it was evaluating the first pilot opportunity, a 50,000 gallon per day wastewater treatment project.
Investments amount											$ 1,000
Common stock, shares Issued (in Shares)		1,013,369,185				1,118,939,374		1,013,369,185
Common stock, shares outstanding (in Shares)		1,013,369,185				1,118,939,374		1,013,369,185
Paid total amount				$ 1,137,267
Membership interest amount				400,000
Compensating amount				737,267
Notes payable to related party								$ 737,267
Purchase price			$ 400,000
Interest rate per annum			10%
Deposit amount										$ 977,500
Public share price (in Dollars per share)										$ 0.1
Special Meeting total number of percentage	81.61%
Sufficient votes Percentage	65%
Other assets		$ 1,479,491				$ 1,431,791		1,479,491
Purchase of market other asset						1,657,920
Paid amount		737,267						$ 737,267
Percentage of repayment								50%
Unsecured promissory notes, receivable						$ 1,657,920
Aggregate amount		1,657,920		$ 2,395,187				$ 1,657,920
Merger percentage				50%
WODI expensed amount		$ 737,267
Shares issued (in Shares)						10,100,000
Restricted shares percentage						25%
Vested shares percentage						6.25%
Common Stock [Member]
Water on demand inc. (Details) [Line Items]
Common stock outstanding percentage						1%
Common Class B [Member]
Water on demand inc. (Details) [Line Items]
Common stock, shares Issued (in Shares)				2,443,750
Common stock, shares outstanding (in Shares)				2,443,750
Purchase of market other asset						$ 400,000
Subsequent Event [Member]
Water on demand inc. (Details) [Line Items]
Special Meeting total (in Shares)	10,514,410
Other assets									$ 6,000,000
Sponsor [Member]
Water on demand inc. (Details) [Line Items]
Membership interest, percentage				100%
Sponsor own shares (in Shares)				2,343,750
Founder shares (in Shares)						50,000
Sponsor [Member] | Common Class B [Member]
Water on demand inc. (Details) [Line Items]
Sponsor own shares (in Shares)			2,343,750
SPAC [Member]
Water on demand inc. (Details) [Line Items]
Purchase price			$ 400,000
Restricted Stock to WODI Board [Member]
Water on demand inc. (Details) [Line Items]
Restricted shares percentage						25%
Vested shares percentage						6.25%
Restricted Stock to WODI Board [Member] | Common Stock [Member]
Water on demand inc. (Details) [Line Items]
Common stock outstanding percentage						1%

Line of Credit (Details)

Line of Credit (Details)	3 Months Ended
	Mar. 31, 2023 USD ($)
Convertible Promissory Notes [Abstract]
Line of credit amount	$ 200,000
Interest rate	26.07%

Assets Held for Sale (Details)

Assets Held for Sale (Details)	3 Months Ended
	Mar. 31, 2023 USD ($) shares
Assets Held For Sale (Details) [Abstract]
Preferred stock fair value	$ 630,000
Residential property amount	230,000
Fair value of the property	$ 400,000
Series T Preferred Stock [Member]
Assets Held For Sale (Details) [Abstract]
Share issued (in Shares) | shares	630

Employee Retention Tax Credit (

Employee Retention Tax Credit (Details)	3 Months Ended
	Mar. 31, 2023 USD ($)
Employee Retention Tax Credit [Abstract]
Aggregate amount	$ 126,879

Commitments and Contingencies (

Commitments and Contingencies (Details)	Mar. 31, 2023 USD ($) m²	Dec. 31, 2022 USD ($)
Commitments and Contingencies (Details) [Line Items]
Monthly rent	$ 8,150
Warrant reserve	$ 20,000	$ 20,000
Mckinney [Member]
Commitments and Contingencies (Details) [Line Items]
Area of land (in Square Meters) | m²	12,000

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)			1 Months Ended			3 Months Ended
	May 02, 2023	May 02, 2023	Apr. 28, 2023	Apr. 25, 2023	Apr. 18, 2023	Mar. 31, 2023	Apr. 14, 2023	Dec. 31, 2022
Subsequent Events (Details) [Line Items]
Other assets (in Dollars)						$ 806,867		$ 806,867
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Other assets (in Dollars)							$ 6,000,000
Aggregate of shares (in Dollars)		$ 5,120,749		$ 5,120,749
Aggregate of shares				2,754,073
Series S Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Aggregate converted shares					167,365
Aggregate shares of common stock					55,788,402
Series Y Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Price per share (in Dollars per share)	$ 2.5
Aggregate of shares (in Dollars)	$ 40,841,585
Series Q Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Aggregate of shares (in Dollars)						$ 70,652,445
Series Q Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Aggregate shares of common stock				40,841,585
Series B Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Designated shares			1,000,000
Convertible per share (in Dollars per share)			$ 5